<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:aa6b7435-acbc-4b85-ac28-815646e75ee4,g:ae0a29f6-3f27-4735-bcf4-870046fe89e3,d:38cf244bc5b742d8ae124c6f37f53505--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:bdx="http://www.bd.com/20221231" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bdx-20221231</title><script >bazadebezolkohpepadr="852337227"</script><script type="text/javascript" src="https://www.sec.gov/akam/13/32cda1fc"  defer></script></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80L2ZyYWc6YTc0ZDg3YTBiMGFhNDNiZDhhZmI2MjNkNDY4MDc5N2EvdGFibGU6OTJhYjdhOTk1ZThiNDU1NWJiMTg0YTg1MGJlOTIwOGIvdGFibGVyYW5nZTo5MmFiN2E5OTVlOGI0NTU1YmIxODRhODUwYmU5MjA4Yl8yLTEtMS0xLTEzMzA3OA_71847657-57c2-41e5-b467-ff9ce22733b6">0000010795</ix:nonNumeric><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80L2ZyYWc6YTc0ZDg3YTBiMGFhNDNiZDhhZmI2MjNkNDY4MDc5N2EvdGFibGU6OTJhYjdhOTk1ZThiNDU1NWJiMTg0YTg1MGJlOTIwOGIvdGFibGVyYW5nZTo5MmFiN2E5OTVlOGI0NTU1YmIxODRhODUwYmU5MjA4Yl8zLTEtMS0xLTEzMzA3OA_5c72a493-b611-4e3b-9880-d983c05f5703">9/30</ix:nonNumeric><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80L2ZyYWc6YTc0ZDg3YTBiMGFhNDNiZDhhZmI2MjNkNDY4MDc5N2EvdGFibGU6OTJhYjdhOTk1ZThiNDU1NWJiMTg0YTg1MGJlOTIwOGIvdGFibGVyYW5nZTo5MmFiN2E5OTVlOGI0NTU1YmIxODRhODUwYmU5MjA4Yl80LTEtMS0xLTEzMzA3OA_ca503770-5f16-4c42-85bc-b4af030febfe">2023</ix:nonNumeric><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80L2ZyYWc6YTc0ZDg3YTBiMGFhNDNiZDhhZmI2MjNkNDY4MDc5N2EvdGFibGU6OTJhYjdhOTk1ZThiNDU1NWJiMTg0YTg1MGJlOTIwOGIvdGFibGVyYW5nZTo5MmFiN2E5OTVlOGI0NTU1YmIxODRhODUwYmU5MjA4Yl81LTEtMS0xLTEzMzA3OA_f8adf6b2-6750-4846-83c9-b84a696224d0">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80L2ZyYWc6YTc0ZDg3YTBiMGFhNDNiZDhhZmI2MjNkNDY4MDc5N2EvdGFibGU6OTJhYjdhOTk1ZThiNDU1NWJiMTg0YTg1MGJlOTIwOGIvdGFibGVyYW5nZTo5MmFiN2E5OTVlOGI0NTU1YmIxODRhODUwYmU5MjA4Yl82LTEtMS0xLTEzMzA3OA_84fb83f5-348a-4dd7-9357-d0de8113dda7">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bdx-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4337978913347bb90f5693d23fee563_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c601ccf1f5e409382de28799876a37e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i830db084d4744714bee7f9f0fc503f3b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.900dueDecember152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11c860549114cc9b749112c04eb0f77_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.401dueMay242023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d304243f92414d8dccbd8631934afb_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes3.020dueMay242025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312ee3ce0db041daa04cb6438ca61cb8_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0.632dueJune42023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc4ca6058c7e4bb9be21017133faa3a3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1.208dueJune42026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ee496b4d994260912b4501561fc04b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes1213NotesDueFebruary122036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63e892a47eb483d8d4b247636eee964_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0000DueAugust132023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb1d973a2ec748d49cb4e0842f71cc7e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bdx:Notes0034DueAugust132025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f3e29d418945a5afade694a98ce9e8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7b883529107040e38066036197ccb84a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c9113445f9c42e790e069a01dd9a817_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aded2f1acd64a42bdc3a71214c66fb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee90c63bad3471e96db0de042ac891e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7cc34afe994321bd0288224eb4784c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb7f03653cfe49bfa08985a0a1252c5a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd4b691859048db9aeadffb7df9719b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbdf32393f5444ec8e0b2bcc9a29a5dd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4cc75087ab416a87f3e00aa59c646b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a8ea1ceabf6421ab3c29b1192ab6dde_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85ea0bfac2f342aeba4ffd26870c3b5b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05ecf298e58c4287a2caa808cbc6185a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide223e85d45649ba9267a72b4ee09a06_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f3ce4ad0d634a3ba7f74edbcfa94c3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04781aeb97ce43068e4cb93aaae4b2d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229dd3b3fdb54f75951cbc977aa0d8ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie34332a2a139410ea7a63b28cb685a71_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4320c421d47d4ee5a665a1f56a71d67c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef1335c691142c9b311ac75c449eff5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32baa088ca94a3fb7e30df94db674b8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfa469e392c4fcaa1bb190b4134ddfc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e92618abed44079d97d41f3feebe5c_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd751a79ccc45379dfbeb74966cec20_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf173fb67dd84611ad99f34c92699339_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49604c02cea844bbaafdcc91e20acc2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb97da8f2fd4649ba1d83cfa7599028_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4db753ac223942efa69afd3dfb67fc18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7dd6988e47843cabc56ee92284b8534_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e48b858caa342578b909d2783834252_I20130924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cdf5de1b3414564953ba8f51fb10178_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625b7ac574a5489daeef5d6406907188_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6a008cc8f344009c7d2204a79f84b4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e790f4097004a7fb16ad4a7f35df651_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4027f02ce9a4952ab5602d1751c0509_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf42d7f55e41468bb1cbe0f1e37d9887_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc52980623d842a6bd330c90f918d482_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d64633676f4648a4bad6fa7892a332_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057566f0dadf4635aa0241c0ec9f573c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb51fb2c78ed413786dd745c206fad4b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f36f299952406fa818ed79e93c316e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab084e7b1454b6799467368a83f6656_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49b7c4f0bcfc4f859f3583baf9406156_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936340060cad4ef0a0104ccdaa3b9abf_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d93fb7f5604237a3b616e8b934587a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6380fafeba4e406b93a580a8981d5de5_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf322089d6724cdaa7de13aadeabc742_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40466428424c45729cdb4318a2b25946_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica163014a61e4241be67cb70951885f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id26acd636f05481391777113c73c7675_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b217af45744e419d4b9572213461d2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cce188b52d349e29f73b752be76a215_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66581b7f5d5448397bd034124b125e9_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bdx:ShareBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73d1cec47524877a3d9c8366498c660_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">bdx:HerniaProductClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bdx:claim</xbrli:measure></xbrli:unit><xbrli:context id="i943eb6e806954ce6be6da8862547dd99_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951cbfd347e54c31bf2573ed3a1a7585_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9347ee133724eeeabc7e69bc41f0520_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90ea862d8f24e2a9ba4b91bb01f6940_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bdx:lawsuit</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>bdx:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i423d5582230b485e8bfc4d66c5b13d54_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bdx:GwinnettCountyGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75c2c1904e8a4932aa21ed4530b0aa1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ProductsandorServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55136b90ffd4da3b185ac706bad63d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4a6e8c8f2aa4baf87dfb8f5f3c73094_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bdx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bdx:segment</xbrli:measure></xbrli:unit><xbrli:context id="i5c4df7d718e44d359b01db2b4f160342_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecdf33e87f6543d9a3d206681b9df46c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbddb4f7cd5347e8ae58c6bb4a5ff9de_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419fb7945e9e4186914030ad5cf002c4_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc7802113c714a16be93a0b3b15d185e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05cd70fd5ee4fa08cc226087515d4e4_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationDeliverySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97b220a882641bebcc06e103d5c6849_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b14b1a39a84c35b2d46e8ed8e3bf66_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6dad728912d45f8b1de39a554de7d91_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i427258e2d22f4014b71b90d4593f2006_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7000b865504ba4b6c647521de00044_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if79cb03408234abeaecac13c70082a9f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:MedicationManagementSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81124ded1d4049aa9f6c7faf5dfd6bbb_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cb0ab9463a04da6a05cd50eb0619825_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe4b8a2b0f1456189f0184ac68cedf3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a521085fe654f4cab3d93f92e803b36_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2f7b16f0f04fbd95794034a329073b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2190f29165034f05b6a290e4eccfb92e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PharmaceuticalSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1243a4869b842c48adc8550b301cf01_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d40d2b45ab04d39b4c014aa23dd7677_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a23268b072a49848e47760823d32be1_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbddcbed92ec45e1b99229561022e2fa_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e99aa477f4140d997e0984307d9ea6c_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id96262e7da19493bac51b0d6719f02a0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfdf070208f6424f92129a571fcd585a_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21083e1dd238457db3cfd8cf7c3d4aa9_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f70b430c7cf4b0f89e334ef902abfce_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7688ea14dd444086bc2e5a8eab4fd009_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idba5dad05a914afa9c9260192569856a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b2358ab91d45e6963d22b757222534_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:IntegratedDiagnosticSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14ca11b98a44fe7ad9604e430feb5fe_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d157ead4f734cbc88d1e4aa43ce1907_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08918e7d413440588b754203e7ed36a0_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21c3b59c897b48b69f6afb62798df128_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if298a9ecce6946209dd231654e34df0a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie377fc496c114bce896d263ee5790bb0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:BiosciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b382f6205f45dc8bd42631dff1cb0e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c8e2d5e44c54ec2ad8cec1ac7310b50_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326b53615edc4e3590b7b892e1c86f1d_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a20ce7de413404bad0c06b89a323ef5_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd37521ebda24aafa17d8e99453a7570_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d29b79904e043e6a527ee8b886a2d0e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9ef13b3152443086e34967533d384a_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8576e53fc144a62b019755528a08d43_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i172aa40d2a2b4f41b2036ed920b8512f_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838604df1d2c4a0f94e38991fc99eb17_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5320c1346c45fb839be5e89c804a23_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1abd1e93bae45b3b153f0e079c9a2ac_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie752a9a07f824cedb1b8f43363ec60cf_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe3e1897c2894932867cb62655e94e2a_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140a53c215ce4d9a9446b24d8c351b83_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i980b8f1a884c4d418f1b99dc9234d37e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c21dbd5f1cd4f57b4dcfb3510f9173b_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba45e410ec3b4abc8b414ce9e5bbab7e_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:PeripheralInterventionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c47eaa89a24c67bedc311413029cc4_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cbf1ca82097469a86ff71022b72d1c1_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia147269082264a118964e3666eae6dd3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic939ace7836444f4a85e1082be7c9fb5_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ec502ce280485494e46ec7354af844_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be2e175e5df492eb7e5696806ecc4b1_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bdx:OrganizationalUnitAxis">bdx:UrologyandCriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e07848af3044982a1b84a5b9d417965_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc29fbd4f56a4458b5c1222e0650f782_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3982372da8648c0830a8d588234c912_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9809c1deaa0e4d178d37dd3922659cd9_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if134802de91a4c1e9adf45eec6d39718_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4c3dc6d70f04fe1b91aa9f7d059cde0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3c2f1baadc243f495d888202e8a4f58_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeaca528a8ce47afa8bb4982196ff70b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6771a6ac30a340b3902a56cd0cfa16b9_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4937715b632e4212bd6723d625df383f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie940a36c0d3d45ab939535bd82ad2e05_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d6ab32417c4fa6b3d23a6de66c6405_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5a4ffa2b364d5dbe59cae615f0ef2c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04d404ff6b7a4256873beee96a1c78dc_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12a8b4c0809d429f8f4e8e07487ff176_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09205dd95ae245c0b9245990244cbdbd_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib086191fba114c828ee0faab4f1391be_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5717df6c7344c82a1f946e8cd9ad74e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebfd3535ccaa4847b138a0dd86fd4aa1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2156aabf71e74425a851790725beed31_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f7bcf9279274b6f85e75ca93ab1591c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i749ac19226b4468c84f9cd4cd6a25300_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id18c9cbad98a4c03b8fe5f882ae9d150_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id49c0ff0927d43dbbde9d4540066833e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bdx:OtherInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadc1877da2a435d8a6a0c0647b4d3cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie220465732bb4f1ca36beeef4c77c632_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ffc8c73de740999be98057b1030bbe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eaaf93142a7430daed0f30bf7b51cd1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57a34902b1164c25bf2e784198077176_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65dabf6b5ce6447585a1293d56818d28_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if701fdd1cd044c79a2860c68eed8e537_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb656747d7c400584c7fc1718ef01d6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bdx:ProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0dba8a603184f7d8c6d201d00df2ac8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifba05eadaf3b404ba573df338edeb748_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b81b2651de4a3b94a8bc0ff9b71f73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib15f8a83f2cc44dda675276a12c3561e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b9e895f15df46719894106cdaa09e57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1de29f9c2ff34c8997e08fa29def0869_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic927ad46f6cb431fa4061147b4da6f75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a6cda300624e4480221d59fb4362a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied876dca6a11435090e382ecb0047c2e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b0a5a6965d424c88d7edc43c098234_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131ce5dc88f34019b471a12d32c5d0ac_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib627bb9e11964cc0bcf9b23b5addf0bc_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cdfa696c686470bb56c1eaefd760b03_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f7af00fe8e742fda4175864193a2662_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ab3e9f4ab6e4487bd8c02b13eff6ce2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id62c9921bcd04b06b7ac3a1c55f10eb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:LifeSciencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cd0f4803b6b472e985331108c0ea22e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bdx:InterventionalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9915b77dd99f4aa8b4b2493a386132a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d645e41c9144a5ebedd76beb21f031b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75497566561742fdb200132a8c9ae4d8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i083801d5a90b41068cdfafd72823e70c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:DebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide421ae3a479478696eca70d565bea54_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892c7476eff5423691c22479ca574bf8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81e17bf495a54ea99d38bfb7ee9c5d2c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie798f6ec2d4a4fb4b0002ebf56335797_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3cd1e62e0974955bb8babd05c8183f8_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica55d26ce1b34b2cb56d6cf1e7496831_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1397a60597fe4950b37bb5611ba6b564_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24137548876c45b7af237c728f1f860f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bdx:FixedToFloatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc75edb830dc448ab8b7f3516e42fdb9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40c12600d8fa41d588430d5d5ad988bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i678e469a5f2543ae9a3e6b53fe928e8e_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id705fc88d8bd40e1995f5e9787b2584c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010795</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="i38cf244bc5b742d8ae124c6f37f53505_1"></div><div style="min-height:40.5pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQy_9be7baf3-b60c-403e-8d04-fc1ff67474f1">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:0.1%"></td><td style="width:2.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6MDk3Mjk3NjYzMmMzNGZkNzk0ZDE1YTgxYTdkZjA4OWQvdGFibGVyYW5nZTowOTcyOTc2NjMyYzM0ZmQ3OTRkMTVhODFhN2RmMDg5ZF8wLTAtMS0xLTEzMzA3OA_a475dfee-b165-4624-9471-43da47198ecd">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xMzI_5898fc1e-8ac2-4cf8-b9ce-16462de055bd">December 31, 2022</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NmViYTZkYWFhMTIyNDYxOGE1NGQ2MzRkZTU3NzJhYTEvdGFibGVyYW5nZTo2ZWJhNmRhYWExMjI0NjE4YTU0ZDYzNGRlNTc3MmFhMV8wLTAtMS0xLTEzMzA3OA_5eedafc4-4e4f-4bc8-beca-5564b7afbe6d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQz_67d294c3-cdd4-46fc-ab80-6ed24c41c86b">001-4802</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQ0_1cd90178-0824-44d6-bb97-a2580f819d8a">Becton, Dickinson and Company</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.545%"><tr><td style="width:1.0%"></td><td style="width:13.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8wLTAtMS0xLTEzMzA3OA_aa1247c9-dcba-4074-ab59-bbb47bec9f2a">New Jersey</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8wLTUtMS0xLTEzMzA3OA_b361b326-2683-4e01-aa88-f0563419b68a">22-0760120</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTAtMS0xLTEzMzA3OA_fbf7b691-a04e-46f0-b60b-d962b575ee46">1 Becton Drive,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTEtMS0xLTEzMzA3OA_62c4ba96-9143-42f3-b1d2-9dcac6febc08">Franklin Lakes,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTItMS0xLTEzMzA3OA_20d90f85-da7d-4529-8f1a-54dd1139640a">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTMtMS0xLTEzMzA3OA_cd2633c0-a4d0-42e2-959e-7bedcfcbb755">07417-1880</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTUtMS0xLTEzMzA3OA_ce225a8b-665c-4a50-9190-eea9594b4b21">(201)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6NTZjYmQ3NDk3ZThiNGUyOTgzOGFkZjVlZDA3NmMzMjkvdGFibGVyYW5nZTo1NmNiZDc0OTdlOGI0ZTI5ODM4YWRmNWVkMDc2YzMyOV8zLTYtMS0xLTEzMzA3OA_04dfaeb3-9d61-4a79-91d4-c49dac10312b">847-6800</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code) </span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:41.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Each Exchange on Which Registered </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4337978913347bb90f5693d23fee563_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xLTAtMS0xLTEzMzA3OA_5bbdba54-3d09-4e07-8d27-fba2772b415a">Common stock, par value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4337978913347bb90f5693d23fee563_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xLTItMS0xLTEzMzA3OA_c30a4482-41cc-4c1b-b7e0-3b35a28ff586">BDX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia4337978913347bb90f5693d23fee563_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xLTQtMS0xLTEzMzA3OA_11fd4d8a-c1a1-41eb-a66d-78f0c51520db">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c601ccf1f5e409382de28799876a37e_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8yLTAtMS0xLTEzMzA3OA_a07edb29-b468-4f47-8202-93b1a14325a9">Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c601ccf1f5e409382de28799876a37e_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8yLTItMS0xLTEzMzA3OA_5a177339-5ed5-489e-ba75-51df2b5263d5">BDXB</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c601ccf1f5e409382de28799876a37e_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8yLTQtMS0xLTEzMzA3OA_84748b59-01e5-4415-bc14-11c6deb2daee">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830db084d4744714bee7f9f0fc503f3b_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl80LTAtMS0xLTEzMzA3OA_2075a678-436e-4f65-8859-f998d1cab69b">1.900% Notes due December 15, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830db084d4744714bee7f9f0fc503f3b_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl80LTItMS0xLTEzMzA3OA_5eea0114-028d-48d5-a9ee-79829fb65ab2">BDX26</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830db084d4744714bee7f9f0fc503f3b_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl80LTQtMS0xLTEzMzA3OA_c801038b-b08e-479a-92dd-659dcb41cf89">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c860549114cc9b749112c04eb0f77_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl81LTAtMS0xLTEzMzA3OA_a366de92-22a3-42e4-adbe-64ebaaceeecb">1.401% Notes due May 24, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c860549114cc9b749112c04eb0f77_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl81LTItMS0xLTEzMzA3OA_c2fb13b1-4418-4da5-86d9-676350d8c019">BDX23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c860549114cc9b749112c04eb0f77_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl81LTQtMS0xLTEzMzA3OA_5be33b3d-d35f-4f3d-9a07-e091205a70b3">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id9d304243f92414d8dccbd8631934afb_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl82LTAtMS0xLTEzMzA3OA_e905269e-0392-4968-b8d1-413e4ce1a068">3.020% Notes due May 24, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id9d304243f92414d8dccbd8631934afb_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl82LTItMS0xLTEzMzA3OA_eb863a2a-b357-4cc3-ba6c-7b3d5cbef887">BDX25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id9d304243f92414d8dccbd8631934afb_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl82LTQtMS0xLTEzMzA3OA_87904deb-8b5f-4668-b162-361a0affa011">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i312ee3ce0db041daa04cb6438ca61cb8_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl83LTAtMS0xLTEzMzA3OA_0a867a71-1b48-4173-b190-1307ea8d5c49">0.632% Notes due June 4, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i312ee3ce0db041daa04cb6438ca61cb8_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl83LTItMS0xLTEzMzA3OA_5c836a43-af33-4fba-9c7d-3b3f91a5c2ec">BDX/23A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i312ee3ce0db041daa04cb6438ca61cb8_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl83LTQtMS0xLTEzMzA3OA_406267b8-62b1-498f-948f-7321d6d452a4">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc4ca6058c7e4bb9be21017133faa3a3_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl84LTAtMS0xLTEzMzA3OA_8df1ecb9-9fa0-4c3e-81a7-aaede65a4e7a">1.208% Notes due June 4, 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc4ca6058c7e4bb9be21017133faa3a3_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl84LTItMS0xLTEzMzA3OA_20533a6d-4efe-4298-a66a-ec39a3b53d9b">BDX/26A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc4ca6058c7e4bb9be21017133faa3a3_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl84LTQtMS0xLTEzMzA3OA_68191631-638b-41ed-95d9-ef791e698496">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64ee496b4d994260912b4501561fc04b_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl85LTAtMS0xLTEzMzA3OA_601a62fa-6a99-481a-8377-f0a18a7ac3b9">1.213% Notes due February 12, 2036</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64ee496b4d994260912b4501561fc04b_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl85LTItMS0xLTEzMzA3OA_128eae61-257e-4282-8b01-c72af2477115">BDX/36</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64ee496b4d994260912b4501561fc04b_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl85LTQtMS0xLTEzMzA3OA_44cfc1f6-c748-4cc5-9c0c-3809c5032e48">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib63e892a47eb483d8d4b247636eee964_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMC0wLTEtMS0xMzMwNzg_8b77c81a-f047-4106-b79c-bdff821ac96e">0.000% Notes due August 13, 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib63e892a47eb483d8d4b247636eee964_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMC0yLTEtMS0xMzMwNzg_314b8334-f3cc-4a72-90f8-755f16b3c996">BDX23B</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib63e892a47eb483d8d4b247636eee964_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMC00LTEtMS0xMzMwNzg_cd3e3bb4-5e6a-4426-916a-e7e4ca9494c4">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb1d973a2ec748d49cb4e0842f71cc7e_D20221001-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMS0wLTEtMS0xMzMwNzg_66d5d761-cdae-4331-aea4-ce2a541885b0">0.034% Notes due August 13, 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb1d973a2ec748d49cb4e0842f71cc7e_D20221001-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMS0yLTEtMS0xMzMwNzg_88d9811f-dab5-4f28-9b6d-c721f3c75ae0">BDX25A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb1d973a2ec748d49cb4e0842f71cc7e_D20221001-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6Yjg4M2Y4YTRiNWM1NDhiOTg0MzQxNmM3ODI2MWE5MzYvdGFibGVyYW5nZTpiODgzZjhhNGI1YzU0OGI5ODQzNDE2Yzc4MjYxYTkzNl8xMS00LTEtMS0xMzMwNzg_8118562a-c4f3-4852-8e31-81861f6a3bfc">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQ1_88706a0f-2d77-4115-a81e-747974f807d1">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQ2_770541f2-77b2-4e86-be7f-6e0f1c117877">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160; &#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.695%"><tr><td style="width:1.0%"></td><td style="width:32.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6OGU3ZDcwMWM4YWYyNDhiYjg5MzRlYmJiYmIxNDRjMzgvdGFibGVyYW5nZTo4ZTdkNzAxYzhhZjI0OGJiODkzNGViYmJiYjE0NGMzOF8wLTAtMS0xLTEzMzA3OA_33bb2519-b015-433b-a194-8d75732ce3ae">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6OGU3ZDcwMWM4YWYyNDhiYjg5MzRlYmJiYmIxNDRjMzgvdGFibGVyYW5nZTo4ZTdkNzAxYzhhZjI0OGJiODkzNGViYmJiYjE0NGMzOF8xLTYtMS0xLTEzMzA3OA_5014fb83-e76f-4b5d-ae3d-93d3fd4018c5">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGFibGU6OGU3ZDcwMWM4YWYyNDhiYjg5MzRlYmJiYmIxNDRjMzgvdGFibGVyYW5nZTo4ZTdkNzAxYzhhZjI0OGJiODkzNGViYmJiYjE0NGMzOF8yLTItMS0xLTEzMzA3OA_77c848a2-c195-47bd-97a4-3a308d49c7b5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNjQ3_93925d78-339c-4d47-ad04-571393956869">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xL2ZyYWc6MWQ2ZThjZDNmZDQ1NDg1ODg4NzdmYWJmYjg4NTc2Y2MvdGV4dHJlZ2lvbjoxZDZlOGNkM2ZkNDU0ODU4ODg3N2ZhYmZiODg1NzZjY18xNTgx_f34d5643-7127-48fd-a798-877044b391b5">283,901,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock, $1.00 par value, outstanding at December&#160;31, 2022.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended December&#160;31, 2022</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_16">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_19">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_25">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_28">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_73">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_76">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_76">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_79">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_79">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Part II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_82">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_85">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_85">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_88">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_88">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_91">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_91">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_94">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_94">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_97">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_97">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_100">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_100">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_103">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_103">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i38cf244bc5b742d8ae124c6f37f53505_106">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i38cf244bc5b742d8ae124c6f37f53505_106">40</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ITEM&#160;1. FINANCIAL STATEMENTS</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars, except per share data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:64.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.369%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMi0xLTEtMS0xMzMwNzg_922f8324-e5d4-4869-9cc0-eb113ba5f39d">4,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMi0zLTEtMS0xMzMwNzg_aaca22a7-c35f-40b1-917a-a49a64b0da7a">4,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMy0xLTEtMS0xMzMwNzg_32f840e2-e5b6-49b6-8e47-31809d563eb4">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMy0zLTEtMS0xMzMwNzg_2bd9f3b0-b926-4603-b964-10b274f5fe41">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNC0xLTEtMS0xMzMwNzg_4b3107a0-3e08-4329-a711-9b3edd972e2c">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNC0zLTEtMS0xMzMwNzg_27269feb-cb95-4624-ac5e-e9a45f23588c">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNS0xLTEtMS0xMzMwNzg_5a0b29ba-3098-49b5-b903-76a920d51891">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNS0zLTEtMS0xMzMwNzg_e26eeafc-1336-433e-960a-7d3aea99fcfc">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNi0xLTEtMS0xMzMwNzg_c1bc526a-04b0-4557-b974-973a94fdf56c">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNi0zLTEtMS0xMzMwNzg_121cfe1f-191b-467f-b1c0-d97936ed31cd">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNy0xLTEtMS0xMzMwNzg_6e79d821-e95c-4882-b729-a8d2133aff41">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfNy0zLTEtMS0xMzMwNzg_2b8d14c7-70e1-48fa-ba2a-c73c91f5f289">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfOC0xLTEtMS0xMzMwNzg_d6fd6adf-7c6b-436e-aa7a-13e00ccc02a5">4,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfOC0zLTEtMS0xMzMwNzg_ed5c4148-25a7-4a37-a1ef-8bb898bc4900">4,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfOS0xLTEtMS0xMzMwNzg_a85d61b2-8ec5-4800-856d-1c11bb5208b0">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfOS0zLTEtMS0xMzMwNzg_7836029f-bf51-4132-9510-df126bf95988">692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTAtMS0xLTEtMTMzMDc4_af9dc534-de63-4719-883d-fbbe6ab00c0b">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTAtMy0xLTEtMTMzMDc4_ee186c0d-8dda-47d7-9bca-66243bfd20b4">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTEtMS0xLTEtMTMzMDc4_91d552eb-27d8-4e74-8b49-82a9c91ded23">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTEtMy0xLTEtMTMzMDc4_b51abc23-5a07-47ce-9a7a-423fcbc87a53">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTItMS0xLTEtMTMzMDc4_e765799f-e418-449c-8fbe-87b1e476bf99">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTItMy0xLTEtMTMzMDc4_82122ffa-9981-43a4-8050-b634b4e2cc6b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations Before Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTMtMS0xLTEtMTMzMDc4_947793e3-1840-4536-942f-5b300085d7ad">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTMtMy0xLTEtMTMzMDc4_c872fc62-7848-4d28-9722-d44d49c8354a">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTQtMS0xLTEtMTMzMDc4_8cdd8857-a28e-4e8d-a3b0-3ed0b8b1b22f">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTQtMy0xLTEtMTMzMDc4_ffb02b5e-a623-4a12-b468-debbd7ad7ffe">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income from Continuing Operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTUtMS0xLTEtMTMzMDc4_5bc88b2b-6b57-43a2-90ad-964b06847b51">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTUtMy0xLTEtMTMzMDc4_424a7290-1736-4eef-9829-8a29991fef19">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTYtMS0xLTEtMTMzMDc4_d7e7d4ac-4692-43f2-ac4b-bc92b5aa6036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTYtMy0xLTEtMTMzMDc4_b30c3e4a-92ad-4b5a-ba42-d964dc0ab45f">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTctMS0xLTEtMTMzMDc4_e669fa0c-5e27-49b9-b7c2-dff1419accef">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTctMy0xLTEtMTMzMDc4_074ab00a-d4a1-40aa-9da3-15a3d2155053">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTgtMS0xLTEtMTMzMDc4_cd519576-ce4a-4dcb-8805-c94fe2dc4cb1">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:PreferredStockDividendsIncomeStatementImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTgtMy0xLTEtMTMzMDc4_3193804c-f8b5-453e-8406-999ff7b33892">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income applicable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTktMS0xLTEtMTMzMDc4_ba84fa8f-cf25-485f-bd18-6f2c7b7d821e">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMTktMy0xLTEtMTMzMDc4_417b865d-9308-4e43-8afe-63d4ad774871">655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjItMS0xLTEtMTMzMDc4_dbb4db1f-f943-4f56-a0b3-b654df9f24d7">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjItMy0xLTEtMTMzMDc4_aa0fdf35-64c6-436a-b2fa-3661dfd7c629">1.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjMtMS0xLTEtMTMzMDc4_1dbc84db-4610-4214-8f84-dde562547e1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjMtMy0xLTEtMTMzMDc4_fab71a2a-7a64-4903-9bc2-7d2724927b3e">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings per Share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjQtMS0xLTEtMTMzMDc4_2bcfa0ad-65a3-48a1-9a00-a7297c16d8c9">1.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjQtMy0xLTEtMTMzMDc4_87ae5e70-25ed-4551-8891-257dfc733404">2.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Continuing Operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjctMS0xLTEtMTMzMDc4_0eaef044-dd56-4ac8-8921-a6ab3e24970f">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjctMy0xLTEtMTMzMDc4_087f808b-9e7c-427a-899c-0fc17cc0c15d">1.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjgtMS0xLTEtMTMzMDc4_98f77fb5-0c4e-4ef4-a365-c4984f3c626a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjgtMy0xLTEtMTMzMDc4_43ccfe12-9773-4b44-bdc7-e22a3b3e15b2">0.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjktMS0xLTEtMTMzMDc4_39397b35-fe9c-4960-ba6a-3fa6324706da">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMjktMy0xLTEtMTMzMDc4_8b96ae90-faa3-4dd8-ae96-0a4c82008f88">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends per Common Share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMzEtMS0xLTEtMTMzMDc4_fb4bea05-c5d8-4eac-9ce2-8bd1ba32e909">0.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xNi9mcmFnOmM5YmQ4MTg4NjgwMDQ4YmJhNDc5ODJlODk3NzMwODllL3RhYmxlOmVmYjI1M2NjNjVkNDRlZGZhMWI0NDE2MDZkNzRhNWNkL3RhYmxlcmFuZ2U6ZWZiMjUzY2M2NWQ0NGVkZmExYjQ0MTYwNmQ3NGE1Y2RfMzEtMy0xLTEtMTMzMDc4_1d5b44ab-f2b0-4b04-95ab-ea9edfaea11f">0.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.801%"><tr><td style="width:1.0%"></td><td style="width:73.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfMi0xLTEtMS0xMzMwNzg_e669fa0c-5e27-49b9-b7c2-dff1419accef">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfMi0zLTEtMS0xMzMwNzg_074ab00a-d4a1-40aa-9da3-15a3d2155053">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive (Loss) Income, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNC0xLTEtMS0xMzMwNzg_e1da9adc-8f9d-4866-ad1d-c9cdcb1e4565">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNC0zLTEtMS0xMzMwNzg_3acdcb22-dcf8-4d90-b160-1bd98ac60778">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension and postretirement plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNS0xLTEtMS0xMzMwNzg_95c1b06e-05e0-471b-830a-edaa33a40f44">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNS0zLTEtMS0xMzMwNzg_19a8119c-a24c-42ac-82b1-bc9dccead366">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNi0xLTEtMS0xMzMwNzg_b1b690e9-94c2-40d7-9bcd-91fef7d4ccea">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNi0zLTEtMS0xMzMwNzg_9af171d3-3768-436b-98c7-980277460b69">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive (Loss) Income, Net of Tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNy0xLTEtMS0xMzMwNzg_90faecf3-5f14-4b88-b726-a5f0a7ccdc37">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfNy0zLTEtMS0xMzMwNzg_89ae26df-887b-4786-a28e-eab2542ea07a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfOC0xLTEtMS0xMzMwNzg_dc7dad5f-d856-4bc2-b58f-d83a1bb3b243">437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8xOS9mcmFnOjMxZjc4ZDY3ZTMxZDQ1ZGFhMzFlYjNlNzE1MzM1NDg1L3RhYmxlOjY3ZTE2OGE3YjE3MjQxN2U4NmJmNmZiNjQ3ZTBlOTQ0L3RhYmxlcmFuZ2U6NjdlMTY4YTdiMTcyNDE3ZTg2YmY2ZmI2NDdlMGU5NDRfOC0zLTEtMS0xMzMwNzg_5c31b086-765a-4e3a-ac75-d307f0e3079d">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars, except per share amounts and numbers of shares</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMy0xLTEtMS0xMzMwNzg_e9cabf74-7cda-469d-97db-cdfe674d277e">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMy0zLTEtMS0xMzMwNzg_bc4165bf-a381-429f-a8dd-46a62aab3794">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNC0xLTEtMS0xMzMwNzg_a835fdbb-e89b-43ad-83a1-7d526ce281aa">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNC0zLTEtMS0xMzMwNzg_1c679fd1-1ec9-42d7-99fe-e824f48a7387">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:OtherShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNS0xLTEtMS0xMzMwNzg_506e48ce-4230-488b-86f5-e8281a7ca2ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:OtherShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNS0zLTEtMS0xMzMwNzg_ef512e37-10b2-4a68-8ea4-0a7a0ecd3778">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNi0xLTEtMS0xMzMwNzg_b4f44e4b-2fb3-4b60-b80c-ce4d5639496f">2,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNi0zLTEtMS0xMzMwNzg_9abd8d83-4abd-4ac3-a646-07e828fc13ea">2,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfOC0xLTEtMS0xMzMwNzg_74d159e9-523a-44da-87b3-0d01f4aee360">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfOC0zLTEtMS0xMzMwNzg_e1832e66-d477-4e03-b5a2-89d75680bb5d">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfOS0xLTEtMS0xMzMwNzg_05f57de0-ac67-480d-b3a7-d6035e319994">443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfOS0zLTEtMS0xMzMwNzg_e9dbfc88-b9e5-484f-9987-405afd0fa8a1">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTAtMS0xLTEtMTMzMDc4_68f57cb7-258d-40c1-9985-5fcb14a7091e">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTAtMy0xLTEtMTMzMDc4_1cb531d0-4b2d-4b2f-98dc-a4ca5ae0676e">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTEtMS0xLTEtMTMzMDc4_0fa833b5-795a-4e87-90a2-2f20c2447de8">3,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTEtMy0xLTEtMTMzMDc4_facf3864-4307-4c1e-a63b-3e20dbf1695b">3,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTMtMS0xLTEtMTMzMDc4_d3ea0aa6-0f55-49cf-8f63-e62b90bb3aa9">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTMtMy0xLTEtMTMzMDc4_620277c1-12ef-40b0-8a63-29b57397e44f">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTUtMS0xLTEtMTMzMDc4_44aabc23-6b8a-4335-ad84-a6e8e1b25083">8,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTUtMy0xLTEtMTMzMDc4_57f2c54c-663a-4b16-8865-af1b7ee50936">8,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTYtMS0xLTEtMTMzMDc4_15580a09-19dc-45e9-8af9-42e226e9cfb0">12,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTYtMy0xLTEtMTMzMDc4_5842ccb5-9d14-4914-89c4-0256f09bd851">12,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowances for depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTctMS0xLTEtMTMzMDc4_4b03def4-b0a2-4a3c-a81e-4c645a47ddbe">6,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTctMy0xLTEtMTMzMDc4_4432e124-0ad8-4753-9993-5267f9a7c5ad">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTgtMS0xLTEtMTMzMDc4_b07a32f0-9078-4342-bcc5-c862cfeae2bc">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTgtMy0xLTEtMTMzMDc4_5dcba63b-66a5-469d-a96a-557452878625">6,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTktMS0xLTEtMTMzMDc4_76bc30c1-a8ca-4a85-a5b5-5808bbe78510">24,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMTktMy0xLTEtMTMzMDc4_a39633c4-63be-4ebe-88ea-21bddbfc4f52">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjAtMS0xLTEtMTMzMDc4_c4eddf98-02fd-4d1f-a5fa-ff85e6cb9943">8,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="bdx:CoreAndDevelopedTechnologyNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjAtMy0xLTEtMTMzMDc4_e75a664c-df61-446b-8196-6041f0ba79cb">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjEtMS0xLTEtMTMzMDc4_a9c98ef3-1327-4703-ae5e-3ec25924e109">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="bdx:FiniteLivedCustomerRelationshipsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjEtMy0xLTEtMTMzMDc4_64aff0a0-a784-4907-a92a-c3dd54f8f731">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Intangibles, Net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjItMS0xLTEtMTMzMDc4_2af7a54d-2787-466c-be66-7fc23f055e1c">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:OtherIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjItMy0xLTEtMTMzMDc4_39cd8dcd-4ea8-4b0c-831a-c458b0f0c8a5">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjQtMS0xLTEtMTMzMDc4_7970cf68-d015-42bd-bf89-e22c59ac5d3e">1,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjQtMy0xLTEtMTMzMDc4_5d54c0cc-b95b-4801-bd31-29aa553ec76b">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjYtMS0xLTEtMTMzMDc4_5c4761af-b436-4942-af19-65b98ddf01e8">53,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjYtMy0xLTEtMTMzMDc4_894d40e7-a907-42c8-9741-5e396ffdb507">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjktMS0xLTEtMTMzMDc4_5de07e85-feeb-4ff3-869c-3ad1019e1ebd">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMjktMy0xLTEtMTMzMDc4_03d29449-1b04-4475-a910-04f8c6d9767c">2,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payables, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzAtMS0xLTEtMTMzMDc4_d1897643-8d67-443d-a0de-d7b3961617e9">5,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzAtMy0xLTEtMTMzMDc4_f8a269fc-3e79-494e-9895-9b3dee17c147">5,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzMtMS0xLTEtMTMzMDc4_412914f8-c75f-4b07-a23e-5c7700d5de2d">7,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzMtMy0xLTEtMTMzMDc4_cdd59b66-bacc-48f3-ad13-0e2f0f310b7e">7,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzQtMS0xLTEtMTMzMDc4_4d15099d-b924-4257-b889-fabb96bf43a0">14,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzQtMy0xLTEtMTMzMDc4_66808479-2f4e-4e18-8213-840b426acf18">13,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Employee Benefit Obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzUtMS0xLTEtMTMzMDc4_de065f31-55bd-4957-ae6a-da36de1f9cb3">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzUtMy0xLTEtMTMzMDc4_6cf13eec-10d5-49c8-bf3a-511579341c06">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzYtMS0xLTEtMTMzMDc4_b7f98527-88fb-47a0-a829-d01e88a24404">4,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzYtMy0xLTEtMTMzMDc4_0fee044d-10da-4127-9dfa-455730ce4614">5,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies (See Note 5)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzgtMS0xLTEtMTMzMDc4_b3ec8399-633e-4539-bfaa-d4c9a5cc223e"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfMzgtMy0xLTEtMTMzMDc4_2c36dd93-cb91-4a12-89fe-4363aaada6e9"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDAtMS0xLTEtMTMzMDc4_67a4c7d7-ff80-4484-b63e-ed20177a789e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDAtMy0xLTEtMTMzMDc4_6c9e41e4-d7c3-41f7-aad3-dc31facc0353">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock &#8212; $<ix:nonFraction unitRef="usdPerShare" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyNzk3Ng_24a98e86-e932-4bf9-bcf7-4d4a9163d87f"><ix:nonFraction unitRef="usdPerShare" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyNzk3Ng_74d316bd-0b90-4919-a967-ea0894f6728f">1</ix:nonFraction></ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">par value; authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyNzk4OQ_14d8a7e5-e7a9-40ba-a54c-024f4aea6761"><ix:nonFraction unitRef="shares" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyNzk4OQ_5d1ca69b-9c92-4088-90d4-6aacd8d5db14">640,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">; issued &#8212; <ix:nonFraction unitRef="shares" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyODAwMw_c2a4e0e3-5199-4e9a-864a-7c52d935c7bf"><ix:nonFraction unitRef="shares" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMC0xLTEtMTMzMDc4L3RleHRyZWdpb246Y2UzZjJlMjgyNGY4NDM0ZDhmNGQxMmY4NDgxMDVmYjRfMTA5OTUxMTYyODAwMw_f028cdfa-fb80-4874-aed7-db4e6f48a003">364,639,901</ix:nonFraction></ix:nonFraction> shares in December 31, 2022 and September 30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMS0xLTEtMTMzMDc4_e5df1384-f7fd-4a31-9ad4-1807aa9f1be3">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDEtMy0xLTEtMTMzMDc4_09d8097d-d7cc-452e-9c6e-d3ca67d03603">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDItMS0xLTEtMTMzMDc4_fced9147-99f7-4923-bc9b-80ff79918f0c">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDItMy0xLTEtMTMzMDc4_f88c448f-0301-4992-8aba-a75299ccf130">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDMtMS0xLTEtMTMzMDc4_6d4d59af-0cf2-441d-943d-112236678a17">15,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDMtMy0xLTEtMTMzMDc4_71394ee4-3bd6-498c-811a-e08f63087d18">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDQtMS0xLTEtMTMzMDc4_f8050537-c095-4635-a321-3d927fdaefb6">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="bdx:CommonStockSharesHeldInEmployeeTrust1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDQtMy0xLTEtMTMzMDc4_bec71436-161c-4f99-870c-1abb274f626f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDUtMS0xLTEtMTMzMDc4_d9deddca-13c6-450b-b5e0-5c8031d68612">8,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDUtMy0xLTEtMTMzMDc4_cb6de042-898b-4e70-a63f-e0b4abd3f007">8,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDYtMS0xLTEtMTMzMDc4_76977867-dca0-4dd8-8876-6558b9cc297a">1,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDYtMy0xLTEtMTMzMDc4_a20c9ab7-3b47-4ed5-bcd4-898b2bd55ffd">1,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 66.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDctMS0xLTEtMTMzMDc4_9bff6ae6-66ff-4505-8388-bb759a114538">25,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDctMy0xLTEtMTMzMDc4_94776c0d-1247-439c-ba49-942abdccbe4a">25,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDgtMS0xLTEtMTMzMDc4_261f4650-2b27-4c21-82ac-26d6c6a1544f">53,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yMi9mcmFnOjU2NjEwN2MzZDI2YjQ4ZmViNDY3MjliNjM0M2QyNDE1L3RhYmxlOjIwOGJmZTliYWU3OTRjZTI4YzliODQ2NjkxY2VkOTk0L3RhYmxlcmFuZ2U6MjA4YmZlOWJhZTc5NGNlMjhjOWI4NDY2OTFjZWQ5OTRfNDgtMy0xLTEtMTMzMDc4_08b0ec00-235b-480d-a0d3-8dcc5216f9c7">52,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Millions of dollars</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMy0xLTEtMS0xMzMwNzg_e307fcfa-073a-4407-9101-c2ebb0c8ee6c">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMy0zLTEtMS0xMzMwNzg_6cf4860e-334d-40b1-9712-ae9208e41998">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNC0xLTEtMS0xMzMwNzg_01107682-e8e3-4b3d-9cb4-ba7907b2ebdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNC0zLTEtMS0xMzMwNzg_23593499-1c2d-45f9-934a-2c896b601df7">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNS0xLTEtMS0xMzMwNzg_e64f0440-e214-415d-9c00-63ca4046d79c">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNS0zLTEtMS0xMzMwNzg_9d7aa00a-3e59-499b-84d9-9daffe776bfb">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to net income from continuing operations to derive net cash provided by continuing operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNy0xLTEtMS0xMzMwNzg_216c11a6-3333-4147-9f9f-cc9089c04e90">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNy0zLTEtMS0xMzMwNzg_36d356a4-6e92-49b3-8060-fe6a4f4dcce7">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfOC0xLTEtMS0xMzMwNzg_97a8d2a3-6558-46fd-a09d-8eeb86fc443d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfOC0zLTEtMS0xMzMwNzg_b21c0ba2-b177-4b93-928d-c63e762a44d4">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfOS0xLTEtMS0xMzMwNzg_3eb7ad78-e513-4208-b21d-68542db4e4e0">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfOS0zLTEtMS0xMzMwNzg_a39eb8e0-cbe3-44e1-9257-0c06a2fe205b">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTAtMS0xLTEtMTMzMDc4_6485ad7e-e61e-4786-85a6-8bf018813378">665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTAtMy0xLTEtMTMzMDc4_65c8b040-731f-478f-8d92-4b6648035e92">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTEtMS0xLTEtMTMzMDc4_afa88f70-967d-424d-876c-04fed20e48fb">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="bdx:IncreaseDecreaseinPensionBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTEtMy0xLTEtMTMzMDc4_d17debfc-e222-48bd-9c69-93a53cdc19d1">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTUtMS0xLTEtMTMzMDc4_8bd88289-fa54-4b0d-b2fb-02c3713f89c2">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTUtMy0xLTEtMTMzMDc4_0124a33d-4613-4982-be90-337feba7f86f">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Continuing Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTYtMS0xLTEtMTMzMDc4_4c210201-4636-47e9-9a01-72fadc83fe20">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTYtMy0xLTEtMTMzMDc4_b680b7a6-1565-4a77-be7b-81423137135e">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTgtMS0xLTEtMTMzMDc4_2580435c-ab50-4b2e-b540-0f5f6744a304">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMTgtMy0xLTEtMTMzMDc4_59813084-3a4a-4839-bc7e-14cb1e84dae0">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjEtMS0xLTEtMTMzMDc4_8a90899b-703e-4672-a005-186199594df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjEtMy0xLTEtMTMzMDc4_2ee4b8d4-e18a-4987-bd14-09e8a0270794">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjMtMS0xLTEtMTMzMDc4_57725837-6b62-432f-8665-1246d203173e">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjMtMy0xLTEtMTMzMDc4_4b931c1f-55d6-4dec-bafd-e161f29913bd">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used for Continuing Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjQtMS0xLTEtMTMzMDc4_5e7f5c23-ea53-40a0-9913-ad4fac6d34ab">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjQtMy0xLTEtMTMzMDc4_e34df762-2e82-4d80-800e-8f2f020f6dcb">682</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjYtMS0xLTEtMTMzMDc4_1a82c855-0ae1-448c-82d1-9e40e5c0c801">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMjYtMy0xLTEtMTMzMDc4_22675cd5-8818-4d4e-a278-acaacd7a8d0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzEtMS0xLTEtMTMzMDc4_70f92a51-969f-4982-a703-ebc78dfc468e">528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzEtMy0xLTEtMTMzMDc4_ac7a918a-d156-4f11-a1a5-02157c859575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzQtMS0xLTEtMTMzMDc4_7ad7d202-50f9-4292-87ab-3b75c4ebbfd5">281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzQtMy0xLTEtMTMzMDc4_8bb1fa9e-24b2-439c-9141-9edbdd58e5e4">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzUtMS0xLTEtMTMzMDc4_9252860e-c308-4c3b-936f-76f8e1671391">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzUtMy0xLTEtMTMzMDc4_fe0b9d38-9711-4c6c-af65-b17712751339">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used for Continuing Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzYtMS0xLTEtMTMzMDc4_d7948b7c-4809-4dff-9739-399dc41932e5">534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzYtMy0xLTEtMTMzMDc4_5040727d-5c63-47c1-8467-4e0b3fc0b12a">327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Discontinued Operations</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzgtMS0xLTEtMTMzMDc4_7ea1b8cb-72de-4178-a7d0-afb09d6f1117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzgtMy0xLTEtMTMzMDc4_6dc703fe-825e-46d8-9576-b79422fc7cc4">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzktMS0xLTEtMTMzMDc4_911e19df-98a7-41d1-bba5-53f11ab07fbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfMzktMy0xLTEtMTMzMDc4_9a39fd09-e6aa-459a-8327-4fb70240d85e">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Discontinued Operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDEtMS0xLTEtMTMzMDc4_b4042881-cf00-4853-8351-c8af8bef3ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDEtMy0xLTEtMTMzMDc4_5fa5bf49-9859-4d43-ba79-9d3b6601aed2">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDItMS0xLTEtMTMzMDc4_0c8849ae-4527-4089-9950-394562d99cb7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDItMy0xLTEtMTMzMDc4_fa131c53-af6d-4974-b354-46a0bacb5a6b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDMtMS0xLTEtMTMzMDc4_30246a5d-cc61-467e-b529-ec22dfd589d0">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDMtMy0xLTEtMTMzMDc4_de3fb36b-2945-4fee-997b-93536d2e32fa">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening Cash and Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDQtMS0xLTEtMTMzMDc4_44cd9dbb-9b72-4bd5-86ae-dbedb3dfba02">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c9113445f9c42e790e069a01dd9a817_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDQtMy0xLTEtMTMzMDc4_99cfef32-f22e-4b07-84f3-e320e18bf35d">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closing Cash and Equivalents and Restricted Cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDUtMS0xLTEtMTMzMDc4_abe9eccb-3503-4702-b692-97c639553e73">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aded2f1acd64a42bdc3a71214c66fb8_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8yNS9mcmFnOmM5MmRlMzYzMGU5MDQ3NTM4ODAzNGE1ZmViOTk3ODNmL3RhYmxlOjVlNzAzNzU5MjFkMjRhYjk4ZGYyOTM0MzhlOWI4MDNlL3RhYmxlcmFuZ2U6NWU3MDM3NTkyMWQyNGFiOThkZjI5MzQzOGU5YjgwM2VfNDUtMy0xLTEtMTMzMDc4_40c49c12-6cd8-4de7-891b-e6671e037eeb">2,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts may not add due to rounding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BECTON, DICKINSON AND COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zMS9mcmFnOjgxMDRmYzNhZTZmNTQyM2RiZTkwYmE4ODBjMjBiMDQ0L3RleHRyZWdpb246ODEwNGZjM2FlNmY1NDIzZGJlOTBiYTg4MGMyMGIwNDRfMTY5OQ_0de5a121-c53e-4582-8ff3-17538985495b" continuedAt="id65d474314f4418aad0e49ad7e782c7e" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="id65d474314f4418aad0e49ad7e782c7e"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of Becton, Dickinson and Company (the "Company" or "BD"), include all adjustments which are of a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. However, the financial statements do not include all information and accompanying notes required for a presentation in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s 2022 Annual Report on Form 10-K.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company. The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment) that was contributed to Embecta Corp (&#8220;Embecta&#8221;) in the spin-off, as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in the Company&#8217;s condensed consolidated financial statements for the three months ended December 31, 2021. Additional disclosures regarding the spin-off are provided in Note 2.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div></ix:continuation><div id="i38cf244bc5b742d8ae124c6f37f53505_34"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RleHRyZWdpb246MTRkZjliMTlhMDExNDc5OTljZGRhZGE0MzIyNjExMzJfNTE1Mw_ca971cec-36ed-4081-893b-907bdf6e8974" continuedAt="ic681e5405e8843aca9b23bfbe0f2ab06" escape="true">Spin-Off of Embecta Corp.</ix:nonNumeric></span></div><ix:continuation id="ic681e5405e8843aca9b23bfbe0f2ab06" continuedAt="ifa6f9cf9ee1143d4b080dab27f4ec209"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company completed the spin-off of its Diabetes Care business as a separate publicly traded company named Embecta through a distribution of Embecta&#8217;s publicly traded common stock (listed on NASDAQ under the ticker symbol &#8220;EMBC&#8221;) to BD&#8217;s shareholders of record as of the close of business on March 22, 2022 (the &#8220;record date&#8221;). The Company distributed one share of Embecta common stock for every five common shares of BD outstanding as of the record date and shareholders received cash in lieu of fractional shares of Embecta common stock. BD retained no ownership interest in Embecta subsequent to the spin-off. The distribution is expected to qualify and has been treated as tax-free to the Company and its shareholders for U.S. federal income tax purposes. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and supply agreements, a lease agreement, a distribution agreement to support commercial operations, a logistics services agreement and other agreements including an employee matters agreement and a tax matters agreement. Under these agreements, the Company will continue to provide certain products and services to Embecta following the spin-off. The agreements do not provide the Company with the ability to influence the operating or financial policies of Embecta subsequent to the spin-off date. Amounts included in the Company&#8217;s condensed consolidated statements of income during the three months ended December&#160;31, 2022 as a result of these agreements were</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> immaterial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifa6f9cf9ee1143d4b080dab27f4ec209" continuedAt="i6ac9732be06b4a5f940a96836f089f80"><div style="margin-top:9pt"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RleHRyZWdpb246MTRkZjliMTlhMDExNDc5OTljZGRhZGE0MzIyNjExMzJfNTE1NA_29d29091-36f3-404c-b370-65b92370df99" continuedAt="i0b5af0afc0914473b9850d7aa50689a4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are as follows:</span></ix:nonNumeric></div><div style="margin-top:6pt;text-align:center"><ix:continuation id="i0b5af0afc0914473b9850d7aa50689a4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.298%"><tr><td style="width:1.0%"></td><td style="width:80.123%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.623%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Millions of dollars</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMi0zLTEtMS0xMzMwNzg_e3a346c2-2d39-44b6-a8af-1040f4938c3a">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMy0zLTEtMS0xMzMwNzg_f6c16602-3d49-427a-b1f6-80a54250efc4">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfNC0zLTEtMS0xMzMwNzg_bb440085-8faf-4c05-b336-8de7a876fe0a">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationsResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfNS0zLTEtMS0xMzMwNzg_d9878f5f-989b-47fd-acb4-661f95488c76">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" sign="-" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfNy0zLTEtMS0xMzMwNzg_ea98e062-8feb-4307-bad8-597723918155">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Costs and Expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfOC0zLTEtMS0xMzMwNzg_74a63145-3ab3-461f-a96f-2173e6f5f671">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfOS0zLTEtMS0xMzMwNzg_6ce6f98b-1f88-477c-b0c5-b91fe7a840f2">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMTAtMy0xLTEtMTMzMDc4_ee61a354-f10a-486e-911d-b3f490f4246d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="bdx:DisposalGroupIncludingDiscontinuedOperationOtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMTItMy0xLTEtMTMzMDc4_3b077fcd-4bbe-4761-bc7c-e8f71e6486a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations Before Income Taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMTMtMy0xLTEtMTMzMDc4_0b4a9297-fd8f-4f56-bab8-5037fab6ed68">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMTQtMy0xLTEtMTMzMDc4_045f1eb3-921e-4605-b9db-a22c476e4404">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from Discontinued Operations, Net of Tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RhYmxlOjk1ZmEzYmRhZTA3MjQ3ZjE4Yjg0YjQxODQxMDJkNjVjL3RhYmxlcmFuZ2U6OTVmYTNiZGFlMDcyNDdmMThiODRiNDE4NDEwMmQ2NWNfMTUtMy0xLTEtMTMzMDc4_478c53ac-c939-497f-80cb-8c89690f32e9">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2021, the Company incurred </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="id5e17ec824bc487f8ff1480038df2128_D20211001-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNC9mcmFnOjE0ZGY5YjE5YTAxMTQ3OTk5Y2RkYWRhNDMyMjYxMTMyL3RleHRyZWdpb246MTRkZjliMTlhMDExNDc5OTljZGRhZGE0MzIyNjExMzJfMTA5OTUxMTYzNTEwMQ_a9374c6c-2a5c-4b48-96b9-81435b67ed84">25</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of separation costs, including those for consulting, legal, tax and other advisory services associated with the spin-off, which were previously recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are now included as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax.</span></div></ix:continuation><div style="margin-top:6pt"><ix:continuation id="i6ac9732be06b4a5f940a96836f089f80" continuedAt="iad427a8300294dc79a67419f48f07007"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from continuing operations were recast to reflect previously eliminated intercompany transactions that occurred between BD and Embecta and that resulted in a third-party sale in the same period.  The impacts of these transactions to Embecta are also reflected as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income from Discontinued Operations, Net of Tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iad427a8300294dc79a67419f48f07007">.</ix:continuation>    </span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><br/>Note 3 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RleHRyZWdpb246NTM5ZGE1YjY4ZDYyNDlhYTliNDdhOTc3ZjhkMjE5YTVfMjYzOA_ad91d442-3abd-4944-b3af-0c021138f396" continuedAt="i33ad4965c37644cba27684570312f6d3" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i33ad4965c37644cba27684570312f6d3" continuedAt="i2f0561c6dc894e0fbe4ccd5c03b054ec"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RleHRyZWdpb246NTM5ZGE1YjY4ZDYyNDlhYTliNDdhOTc3ZjhkMjE5YTVfMjY0Mg_a0a08f2b-fd4d-42ce-aeba-8c85bfeeb465" continuedAt="if3c7fadabf2540f181d4ac55a5a3e203" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in certain components of shareholders' equity for the first quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee90c63bad3471e96db0de042ac891e_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi0xLTEtMS0xMzMwNzg_a32df5fe-fd23-44f4-9641-5889768fdf94">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7cc34afe994321bd0288224eb4784c_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi0zLTEtMS0xMzMwNzg_8021e6a7-a0de-4aab-880b-b4580beb6365">19,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7f03653cfe49bfa08985a0a1252c5a_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi01LTEtMS0xMzMwNzg_583275dc-09f0-4043-87da-023da21c5382">15,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd4b691859048db9aeadffb7df9719b_I20220930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi03LTEtMS0xMzMwNzg_b603e9d7-393b-4404-880a-8fd18fda2e4e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibbdf32393f5444ec8e0b2bcc9a29a5dd_I20220930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi05LTEtMS0xMzMwNzg_d75f1af8-5bd4-4788-8afd-56b15a581828">81,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbdf32393f5444ec8e0b2bcc9a29a5dd_I20220930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMi0xMS0xLTEtMTMzMDc4_514293ab-020e-4b70-a28f-a4a3edcc4ee1">8,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4cc75087ab416a87f3e00aa59c646b_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMy01LTEtMS0xMzMwNzg_55d06d66-ce64-470b-8bf9-c07b65047360">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNC0wLTEtMS0xMzMwNzgvdGV4dHJlZ2lvbjpmOTNjY2M0NjdmNmM0ZDY5YThkZjZjMmY5MzJkNGI4N18yMg_9db65d7b-6076-4955-9ec2-f601454625cf">0.91</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4cc75087ab416a87f3e00aa59c646b_D20221001-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNC01LTEtMS0xMzMwNzg_d3d960b7-0d64-4adb-91fa-5a9ac180da8e">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f4cc75087ab416a87f3e00aa59c646b_D20221001-20221231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNS01LTEtMS0xMzMwNzg_174d9904-e416-4436-8051-fbf4e742e1a4">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a8ea1ceabf6421ab3c29b1192ab6dde_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNi0zLTEtMS0xMzMwNzg_8c8f98c9-26f7-4e67-b67e-f084dea04f70">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85ea0bfac2f342aeba4ffd26870c3b5b_D20221001-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNi05LTEtMS0xMzMwNzg_2d65a859-87a8-4bdb-b5cc-e0a4000bb9d6">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85ea0bfac2f342aeba4ffd26870c3b5b_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNi0xMS0xLTEtMTMzMDc4_badbf34b-ace6-49b3-ba25-905320b8bf76">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a8ea1ceabf6421ab3c29b1192ab6dde_D20221001-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfNy0zLTEtMS0xMzMwNzg_e51db095-7306-4668-ae7c-1d8d06b74a0d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i85ea0bfac2f342aeba4ffd26870c3b5b_D20221001-20221231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfOC05LTEtMS0xMzMwNzg_ddc9d592-c37a-4304-b615-ff9e9eb5e990">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05ecf298e58c4287a2caa808cbc6185a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtMS0xLTEtMTMzMDc4_4d8a0e21-b496-4461-818a-db5ac47a4c3a">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide223e85d45649ba9267a72b4ee09a06_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtMy0xLTEtMTMzMDc4_022f4c0c-77e8-40a0-b85d-ac1096da4aa3">19,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f3ce4ad0d634a3ba7f74edbcfa94c3a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtNS0xLTEtMTMzMDc4_4f846dd3-1628-4801-93d0-8ed5376fde7b">15,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04781aeb97ce43068e4cb93aaae4b2d7_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtNy0xLTEtMTMzMDc4_a49c811e-72f5-4c30-99f9-5219de7239ca">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i229dd3b3fdb54f75951cbc977aa0d8ca_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtOS0xLTEtMTMzMDc4_4d728efd-1696-4eac-a20f-386298a19232">80,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229dd3b3fdb54f75951cbc977aa0d8ca_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjhmMmRlOWNlNzVmNzQ0Mjg4NmQzMGE2ZjljMjY1OTNmL3RhYmxlcmFuZ2U6OGYyZGU5Y2U3NWY3NDQyODg2ZDMwYTZmOWMyNjU5M2ZfMTEtMTEtMS0xLTEzMzA3OA_e9cb1552-1cf6-4194-b186-0cf443c6bd8e">8,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2f0561c6dc894e0fbe4ccd5c03b054ec" continuedAt="ib0f1dd1660494ddc97e9efa25baf6523"><ix:continuation id="if3c7fadabf2540f181d4ac55a5a3e203"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:35.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.027%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock&#160; Issued<br/>at&#160;Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess&#160;of<br/>Par&#160;Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred<br/>Compensation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares&#160;(in<br/>thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34332a2a139410ea7a63b28cb685a71_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi0xLTEtMS0xMzMwNzg_98f57e3c-ef8b-4798-b2d0-e7e228195b53">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4320c421d47d4ee5a665a1f56a71d67c_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi0zLTEtMS0xMzMwNzg_186b8115-0a28-4277-a03c-d7d16b318a5a">19,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef1335c691142c9b311ac75c449eff5_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi01LTEtMS0xMzMwNzg_2a8e31b8-6b63-4c5d-8291-b315d98de9a4">13,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32baa088ca94a3fb7e30df94db674b8_I20210930" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi03LTEtMS0xMzMwNzg_64643601-3801-48b1-817d-282421c460dc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icdfa469e392c4fcaa1bb190b4134ddfc_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi05LTEtMS0xMzMwNzg_38d8340a-81fc-4318-aba0-945e457e655a">80,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdfa469e392c4fcaa1bb190b4134ddfc_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMi0xMS0xLTEtMTMzMDc4_83531773-08de-4595-9a86-f6fe967be089">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e92618abed44079d97d41f3feebe5c_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMy01LTEtMS0xMzMwNzg_26ec4ed5-1180-485f-972e-79722c369cd0">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNC0wLTEtMS0xMzMwNzgvdGV4dHJlZ2lvbjo1YTFmMGJmMWE3ZTQ0MjU2OWVjYjI0MGE5MWY0ZjJmZl8yMg_6ab5d620-ab0e-4eb2-b6b0-6a49ee43d0b7">0.87</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3e92618abed44079d97d41f3feebe5c_D20211001-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNC01LTEtMS0xMzMwNzg_bbfb4811-7abc-4b33-bdb7-a0c265f06c98">248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3e92618abed44079d97d41f3feebe5c_D20211001-20211231" decimals="-6" name="us-gaap:DividendsPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNS01LTEtMS0xMzMwNzg_738f4141-1682-41ca-99a3-e0432c4aebf1">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for share-based compensation and other plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbd751a79ccc45379dfbeb74966cec20_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNi0zLTEtMS0xMzMwNzg_34c236cb-368a-462c-82ab-fe7368b4e308">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNi05LTEtMS0xMzMwNzg_c2a0eddd-bd44-4450-b936-ebc18e924703">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNi0xMS0xLTEtMTMzMDc4_29f6398d-b379-4d71-b4bf-3a7787608267">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbd751a79ccc45379dfbeb74966cec20_D20211001-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfNy0zLTEtMS0xMzMwNzg_f90d4518-d533-497a-a7d0-a9681e2e0aeb">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock held in trusts, net (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231" decimals="-3" sign="-" name="bdx:CommonStockHeldInTrustsNetShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfOC05LTEtMS0xMzMwNzg_5bb789ef-f5ca-479d-8b0e-0b18ed8c391b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbd751a79ccc45379dfbeb74966cec20_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtMy0xLTEtMTM5NzA1_b37da88f-2900-4e7d-825e-95810daf040f">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtOS0xLTEtMTQxOTU1_605a1584-a749-4e00-a0c7-d75549d3e5a3">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea4b1a8c0e044605a67fc1dc38bb5aa2_D20211001-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtMTEtMS0xLTEzOTcxNg_6532f066-ebd6-4862-9bed-8c5fb6c22789">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf173fb67dd84611ad99f34c92699339_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtMS0xLTEtMTMzMDc4_bd78eaea-222e-4f29-8a7b-58edb3dccfca">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49604c02cea844bbaafdcc91e20acc2d_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtMy0xLTEtMTMzMDc4_e1782523-51db-4633-a550-50ff64548b17">19,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb97da8f2fd4649ba1d83cfa7599028_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtNS0xLTEtMTMzMDc4_33e812cd-8fe4-466e-90a3-04ef14ae26de">14,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db753ac223942efa69afd3dfb67fc18_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtNy0xLTEtMTMzMDc4_b137270d-5d02-4a16-9fa9-1834836997b9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if7dd6988e47843cabc56ee92284b8534_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtOS0xLTEtMTMzMDc4_79eaa155-2398-45f1-a05b-0a95aa3d0893">79,869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7dd6988e47843cabc56ee92284b8534_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjU0ZmJiOGMyZjI0YjQ5ZGE4MjFiM2E4MDdhZTUxYzc3L3RhYmxlcmFuZ2U6NTRmYmI4YzJmMjRiNDlkYTgyMWIzYTgwN2FlNTFjNzdfMTAtMTEtMS0xLTEzMzA3OA_0054034e-fc89-461a-891c-ce4309082bff">7,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Common stock held in trusts consists of the Company&#8217;s shares held in rabbi trusts in connection with deferred compensation under the Company&#8217;s employee salary and bonus deferral plan and directors&#8217; deferral plan.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares received upon final settlement of an accelerated share repurchase agreement, and the related forward sale contract, entered into during the fourth quarter of fiscal year 2021. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he share repurchases were made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for <ix:nonFraction unitRef="shares" contextRef="i5e48b858caa342578b909d2783834252_I20130924" decimals="-6" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RleHRyZWdpb246NTM5ZGE1YjY4ZDYyNDlhYTliNDdhOTc3ZjhkMjE5YTVfOTgw_31999c19-1f0c-427c-a120-1b60bb216bc0">10</ix:nonFraction>&#160;million shares, for which there is no expiration date. In November 2021, the Board of Directors authorized the Company to repurchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i9cdf5de1b3414564953ba8f51fb10178_I20211130" decimals="-6" name="bdx:StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RleHRyZWdpb246NTM5ZGE1YjY4ZDYyNDlhYTliNDdhOTc3ZjhkMjE5YTVfMTEyOQ_c70febb7-6262-4dd2-9075-d60df9626e25">10</ix:nonFraction>&#160;million shares of BD common stock, for which there is also no expiration date.</span></div></ix:continuation></ix:continuation><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib0f1dd1660494ddc97e9efa25baf6523"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RleHRyZWdpb246NTM5ZGE1YjY4ZDYyNDlhYTliNDdhOTc3ZjhkMjE5YTVfMjY0NA_486a3422-e293-4666-9742-d85b5f72ddff" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components and changes of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the first quarters of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:47.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMS0xLTEtMS0xMzMwNzg_a20c9ab7-3b47-4ed5-bcd4-898b2bd55ffd">1,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i625b7ac574a5489daeef5d6406907188_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMS0zLTEtMS0xMzMwNzg_6055b336-0e40-4039-b07a-6136a0e49933">987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e6a008cc8f344009c7d2204a79f84b4_I20220930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMS01LTEtMS0xMzMwNzg_31cdefb0-b1e1-434d-bcb8-973593b73f52">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e790f4097004a7fb16ad4a7f35df651_I20220930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMS03LTEtMS0xMzMwNzg_1bd490e3-ff0c-428a-a8a1-9fa47760226d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMi0xLTEtMS0xMzMwNzg_63789852-dbff-4be5-b604-bebdb15d8cda">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4027f02ce9a4952ab5602d1751c0509_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMi0zLTEtMS0xMzMwNzg_a7368a7d-f37f-4a4a-a8e0-caa5d3866a07">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf42d7f55e41468bb1cbe0f1e37d9887_D20221001-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMi01LTEtMS0xMzMwNzg_027530f2-3238-4db4-b98a-b28d26b2728d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc52980623d842a6bd330c90f918d482_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMi03LTEtMS0xMzMwNzg_31d53a2c-1458-4b00-81ea-68f32f1e768b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMy0xLTEtMS0xMzMwNzg_5a25eda7-d3ec-4730-9ee1-466de48a1080">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4027f02ce9a4952ab5602d1751c0509_D20221001-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMy0zLTEtMS0xMzMwNzg_18497eb3-f386-45a7-a43c-a22439ff4c46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf42d7f55e41468bb1cbe0f1e37d9887_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMy01LTEtMS0xMzMwNzg_ed6f1223-000e-4a6e-93cf-88ecf26b15a1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc52980623d842a6bd330c90f918d482_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfMy03LTEtMS0xMzMwNzg_56b25f3d-74ae-4f60-af3e-86260b9360d1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfNC0xLTEtMS0xMzMwNzg_b8ae3384-0dea-4d5d-aaa0-d70f3cbf0c4c">1,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42d64633676f4648a4bad6fa7892a332_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfNC0zLTEtMS0xMzMwNzg_29dc538d-830a-486b-a2c6-1cdd63ecafef">1,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i057566f0dadf4635aa0241c0ec9f573c_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfNC01LTEtMS0xMzMwNzg_e042ee6b-8739-45e4-9f76-13f667a26f87">563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb51fb2c78ed413786dd745c206fad4b_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOmZkYzBiN2UzNGNmZDRkZTVhYzEwYTEzYmRjODI4ODIxL3RhYmxlcmFuZ2U6ZmRjMGI3ZTM0Y2ZkNGRlNWFjMTBhMTNiZGM4Mjg4MjFfNC03LTEtMS0xMzMwNzg_0eecbaa4-5cf1-4602-a36c-db8ef87fd1b4">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:47.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency<br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benefit&#160;Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Flow Hedges</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c9113445f9c42e790e069a01dd9a817_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMS0xLTEtMS0xMzMwNzg_7bea2ad2-12a3-4812-85ec-dca6988b5503">2,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93f36f299952406fa818ed79e93c316e_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMS0zLTEtMS0xMzMwNzg_fe35b168-f4bf-46c9-af15-0c39ae46718a">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ab084e7b1454b6799467368a83f6656_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMS01LTEtMS0xMzMwNzg_71aff72b-f71f-43b9-ac70-16f32d6b023c">784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49b7c4f0bcfc4f859f3583baf9406156_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMS03LTEtMS0xMzMwNzg_720d720e-d5ed-485f-bfcb-a4dfe498bf57">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMi0xLTEtMS0xMzMwNzg_c5b2301c-6830-4a76-8552-e82847182b62">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936340060cad4ef0a0104ccdaa3b9abf_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMi0zLTEtMS0xMzMwNzg_14a00b97-4e3b-4499-b932-5b1fcc3fc32f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d93fb7f5604237a3b616e8b934587a_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMi01LTEtMS0xMzMwNzg_5e468744-e3c6-4838-9154-9015baf1fd99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6380fafeba4e406b93a580a8981d5de5_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMi03LTEtMS0xMzMwNzg_d588d803-9728-4514-aca0-1cf9f1d19e8d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified into income, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMy0xLTEtMS0xMzMwNzg_8878f09b-7b2c-4d32-a726-e371ed9cb9ba">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936340060cad4ef0a0104ccdaa3b9abf_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMy0zLTEtMS0xMzMwNzg_de5d029f-b765-4478-b0f9-d16e23c6cfe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88d93fb7f5604237a3b616e8b934587a_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMy01LTEtMS0xMzMwNzg_783112b2-28f8-4a14-a08d-39c3155c37f5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6380fafeba4e406b93a580a8981d5de5_D20211001-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfMy03LTEtMS0xMzMwNzg_8908b2fc-cd81-45fe-8941-3fbf2c01360d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aded2f1acd64a42bdc3a71214c66fb8_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfNC0xLTEtMS0xMzMwNzg_3eea9750-5be4-46dc-82f3-737910b0e2ac">2,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf322089d6724cdaa7de13aadeabc742_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfNC0zLTEtMS0xMzMwNzg_058b44bd-b460-4306-8024-904ae77a0af4">1,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40466428424c45729cdb4318a2b25946_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfNC01LTEtMS0xMzMwNzg_1542d44c-f4fc-48cd-9247-83abde9b6b12">774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica163014a61e4241be67cb70951885f6_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV8zNy9mcmFnOjUzOWRhNWI2OGQ2MjQ5YWE5YjQ3YTk3N2Y4ZDIxOWE1L3RhYmxlOjQ2MWRmNzQ5ZGYwYjRhMTFhYjk3ODIxNGJkMDBkNDdmL3RhYmxlcmFuZ2U6NDYxZGY3NDlkZjBiNGExMWFiOTc4MjE0YmQwMGQ0N2ZfNC03LTEtMS0xMzMwNzg_0f518f06-f99b-4f66-849d-e59025a4ea1b">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of foreign currency translation recognized in other comprehensive income during the three months ended December&#160;31, 2022 and 2021 included net (losses) gains relating to net investment hedges.  Disclosures regarding amounts the Company recognized in other comprehensive income relating to cash flow hedges during the three months ended December&#160;31, 2022 and 2021 are provided in Note 11.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impacts for amounts recognized in other comprehensive income (loss) before reclassifications and for reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to benefit plans and cash flow hedges during the three months ended December&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div></ix:continuation><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:48.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.821%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.826%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i38cf244bc5b742d8ae124c6f37f53505_40"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RleHRyZWdpb246OGY1MmQ1ZWZkNTUxNDcwOTkyMjYyODAxNGZiZTI3NGZfNzA3_4f71fd9b-3b1e-41a4-aa3a-3b3f9ccd6d1d" continuedAt="i1b6ec2c6533c4f0f8e88f8c0d89e1ea6" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i1b6ec2c6533c4f0f8e88f8c0d89e1ea6"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RleHRyZWdpb246OGY1MmQ1ZWZkNTUxNDcwOTkyMjYyODAxNGZiZTI3NGZfNzE4_2f992a5e-ea2d-4721-a425-abe537a3f97a" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.391%"><tr><td style="width:1.0%"></td><td style="width:65.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfMi0xLTEtMS0xMzMwNzg_26b0caa6-c471-48c3-a64a-bdeb940ab31b">283,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfMi0zLTEtMS0xMzMwNzg_8789776d-1927-4938-a9c7-a43d62b4b953">284,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive share equivalents from share-based plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfMy0xLTEtMS0xMzMwNzg_5710fa00-6269-4513-8065-073c7bec720c">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfMy0zLTEtMS0xMzMwNzg_12dd91f3-0bee-429a-8549-de22f98cbb25">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average common and common equivalent shares outstanding &#8211; assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfNS0xLTEtMS0xMzMwNzg_6c0defdf-ad69-4c98-b0fc-be37a39b91f5">285,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfNS0zLTEtMS0xMzMwNzg_fa2f58a4-cbd0-407e-8c74-cdafa4691bbc">286,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share equivalents excluded from the diluted shares outstanding calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandatory convertible preferred stock (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id26acd636f05481391777113c73c7675_D20221001-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfOC0xLTEtMS0xMzMwNzg_bd2de525-6262-4bdb-8b05-e40c04ee3460">5,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4b217af45744e419d4b9572213461d2_D20211001-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfOC0zLTEtMS0xMzMwNzg_f7a35064-39a8-46fe-ac23-5f7bbeae1824">5,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based plans (b)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cce188b52d349e29f73b752be76a215_D20221001-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfOS0xLTEtMS0xMzMwNzg_97a384f6-26ee-44b0-b62a-acd183ef90d0">1,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie66581b7f5d5448397bd034124b125e9_D20211001-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80MC9mcmFnOjhmNTJkNWVmZDU1MTQ3MDk5MjI2MjgwMTRmYmUyNzRmL3RhYmxlOjA5YzgyYzA1OWU2OTQ0ZjI4ZjRhN2VmODNlYTkzNWY2L3RhYmxlcmFuZ2U6MDljODJjMDU5ZTY5NDRmMjhmNGE3ZWY4M2VhOTM1ZjZfOS0zLTEtMS0xMzMwNzg_37082eaf-a0af-4d92-9212-9b6f1a7bd3bd">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company&#8217;s common shares.</span></div></ix:nonNumeric></ix:continuation><div id="i38cf244bc5b742d8ae124c6f37f53505_43"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTM4NjE_d8b5b746-54f6-4e89-82d1-b9e886ad1c16" continuedAt="i8c7733cb9cba47f980c383fdaf563c7e" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="i8c7733cb9cba47f980c383fdaf563c7e" continuedAt="ie35a5c863e1840d9944546d49b24b647"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTM4NzI_b9707dbc-beb1-4bbd-aec5-7e5e28255b14" continuedAt="i7cbbc1ce62ad407fbc71a490763943cb" escape="true">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability and environmental matters in certain U.S. and international locations. Given the uncertain nature of litigation generally, the Company is not able, in all cases, to estimate the amount or range of loss that could result from an unfavorable outcome of litigation in which the Company is a party. In accordance with U.S. GAAP, the Company establishes accruals to the extent probable future losses are estimable (and in the case of environmental matters, without considering possible third-party recoveries). With respect to putative class action lawsuits in the United States and certain of the Canadian lawsuits described below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; (ii) the Company has not received and reviewed complete information regarding all or certain of the plaintiffs and their medical conditions; and/or (iii) there are significant factual issues to be resolved. In addition, there is uncertainty as to the likelihood of a class being certified or the ultimate size of any class. With respect to the civil investigative demands (&#8220;CIDs&#8221;) served by the Department of Justice which are discussed below, the Company is unable to estimate a range of reasonably possible losses for the following reasons: (i) all or certain of the proceedings are in early stages; and/or (ii) there are significant factual and legal issues to be resolved.</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Liability Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company is defending approximately <ix:nonFraction unitRef="claim" contextRef="ie73d1cec47524877a3d9c8366498c660_I20221231" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTc1OA_0ae5408d-4ff1-43c3-a54b-9ce63340b672">32,305</ix:nonFraction> product liability claims involving the Company&#8217;s line of hernia repair devices (collectively, the &#8220;Hernia Product Claims&#8221;). The majority of those claims are currently pending in a coordinated proceeding in Rhode Island State Court (&#8220;RI&#8221;) and in a federal multi-district litigation (&#8220;MDL&#8221;) established in the Southern District of Ohio, but claims are also pending in other state and/or federal court jurisdictions. In addition, those claims include multiple putative class actions in Canada. Generally, the Hernia Product Claims seek damages for personal injury allegedly resulting from use of the products.  From time to time, the Company engages in resolution discussions with plaintiffs&#8217; law firms regarding certain of the Hernia Product Claims, but the Company also intends to vigorously defend Hernia Product Claims that do not settle, including through litigation.  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in the hernia MDL resulted in a complete defense verdict in favor of the Company in September 2021.  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The second hernia MDL bellwether resulted in a $<ix:nonFraction unitRef="usd" contextRef="i943eb6e806954ce6be6da8862547dd99_D20220401-20220430" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMjgzOA_03e7c7a0-d613-4530-942b-76132dced78e">255</ix:nonFraction>&#160;thousand verdict in April 2022. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The first bellwether trial in RI resulted in a $<ix:nonFraction unitRef="usd" contextRef="i951cbfd347e54c31bf2573ed3a1a7585_D20220801-20220831" decimals="-5" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTA5OTUxMTY0MTgyNg_8f93c593-0b20-48bc-b484-3afe1ba6fd7f">4.8</ix:nonFraction>&#160;million verdict in August 2022, which the Company plans to appeal.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials are currently scheduled in state and/or federal courts, including an additional bellwether trial in the MDL in May 2023. The Company also expects additional trials of Hernia Product Claims to take place over the next 12 months in RI, including trials in June 2023 and October 2023.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continues to be a defendant in certain other mass tort litigation. As of December&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of pelvic mesh products, the majority of which are pending in various federal court jurisdictions and in a coordinated proceeding in New Jersey Superior Court. Also, as of December&#160;31, 2022, the Company is defending product liability claims involving the Company&#8217;s line of inferior vena cava (&#8220;IVC&#8221;) filter products. The majority of those claims are pending in various federal court jurisdictions after having been remanded from the MDL in the United States District Court for the District of Arizona.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most product liability litigations like those described above, plaintiffs allege a wide variety of claims, ranging from allegations of serious injury caused by the products to efforts to obtain compensation notwithstanding the absence of any injury. In many of these cases, the Company has not yet received and reviewed complete information regarding the plaintiffs and their medical conditions and, consequently, is unable to fully evaluate the claims. The Company expects that it will receive and review additional information regarding any remaining unsettled product liability matters.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, a putative class action captioned Kabak v. Becton, Dickinson and Company, et al., Civ. No. 2:20-cv-02155 (SRC) (CLW), now captioned Industriens Pensionsforsikring v. Becton, Dickinson and Company, et al., was filed in the U.S. District Court for the District of New Jersey against the Company and certain of its officers. The complaint, which purports to be brought on behalf of all persons (other than defendants) who purchased or otherwise acquired the Company's common stock from November 5, 2019 through February 5, 2020, asserts claims for purported violations of Sections 10 and 20 of the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;) and Securities and Exchange Commission (&#8220;SEC&#8221;) Rule 10b-5 promulgated thereunder, and seeks, among other things, damages and costs. The complaint alleges that defendants concealed certain material information regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps, allegedly rendering certain public statements about the Company&#8217;s business, operations and prospects false or misleading, thereby allegedly causing investors to purchase stock at an inflated price. After an initial without prejudice dismissal, the plaintiff filed amended pleadings, which the Company in turn moved to dismiss. Ultimately, the court permitted certain aspects of the case to proceed. An answer with affirmative defenses </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie35a5c863e1840d9944546d49b24b647" continuedAt="i94c5e489c4b3464d8cdfde5089f41e31"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was thereafter filed on October 3, 2022. Discovery has commenced and plaintiff&#8217;s motion for class certification was filed on January 17, 2023. The Company believes that it has strong defenses to the allegations that were not dismissed and it intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 2, 2020, a putative shareholder derivative action captioned Jankowski v. Forlenza, et al., Civ. No. 2:20-cv-15474, was filed in the U.S. District Court for the District of New Jersey by a shareholder, derivatively on behalf of the Company, against certain of the Company&#8217;s directors and officers. The complaint asserts claims for breach of fiduciary duty, violations of sections 10(b), 14(a) and 21D of the Exchange Act, and insider trading. The complaint principally alleges that the Company made misleading statements regarding Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> infusion pumps in a proxy statement and other SEC filings. A second derivative action was filed on January 24, 2021, and the two actions were consolidated. In March 2021, the Company received letters from two additional shareholders which, in general, mirrored the allegations in the derivative actions, and demanded, among other things, that the Board of Directors pursue claims against members of management for claimed breaches of fiduciary duties. Consistent with New Jersey law, the Board appointed a special committee to review the allegations and demands in the derivative actions and demand letters. Following an investigation, the special committee determined that no action was warranted, and rejected the shareholders&#8217; demands, communicating its determination to counsel for the shareholders. On January 10, 2023, one of the two shareholders referenced above filed a separate derivative action that: (i) is generally consistent with the shareholder letter and the two prior actions; and (ii) purports to challenge the reasonableness of the special committee&#8217;s process and determination. The Company believes that is has strong defenses to these claims and intends to defend itself vigorously.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2017, the Company was sued by a competitor in the Northern District of New York, alleging antitrust violations related to certain aspects of the Company&#8217;s medical delivery solutions business in a case captioned AngioDynamics, Inc. v. C. R. Bard, Inc. et al., Civ. No. 1:17-CV-0598. Trial began on September 19, 2022, resulting in a complete defense verdict for the Company on October 6, 2022, from which AngioDynamics has filed a notice of appeal. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company received a subpoena from the Enforcement Division of the SEC requesting information from the Company relating to, among other things, Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps. The Company is cooperating with the SEC and responding to these requests. The Company cannot anticipate the timing, scope, outcome or possible impact of the investigation, financial or otherwise. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the Department of Justice served the Company and CareFusion with CIDs seeking information regarding certain of CareFusion&#8217;s contracts with the Department of Veteran&#8217;s Affairs for certain products, including Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Pyxis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, in connection with a civil investigation of possible violations of the False Claims Act, and the government recently expanded the investigation to include several additional contracts. The government has made several requests for documents and interviews or depositions of Company personnel. The Company is cooperating with the government and responding to these requests.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company received a CID related to an inquiry initiated by the Northern District of Georgia in 2018.  The requests concern sales and marketing practices with respect to certain aspects of the Company&#8217;s urology business. The government has made requests for documents and has interviewed employees. The inquiry is ongoing and the Company is cooperating with the government and responding to its requests. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company was served with a complaint from the New Mexico Attorney General, alleging violations of the state&#8217;s consumer protection laws in connection with the sales and marketing of its IVC filters. The Company&#8217;s motion to dismiss certain of the claims was granted on May 10, 2022 and discovery is proceeding as to the remaining claims. The Company intends to vigorously defend itself in the litigation. As the case is in its early stages, the Company cannot anticipate the timing, scope, outcome or possible impact at present.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has been sued in state and federal courts in Georgia by plaintiffs who work or reside near Company facilities in Covington, GA, where ethylene oxide (&#8220;EtO&#8221;) sterilization activities take place. The plaintiffs in those cases seek compensatory and punitive damages. Pursuant to Georgia statute, punitive damages in these cases are generally capped at $<ix:nonFraction unitRef="usd" contextRef="ic9347ee133724eeeabc7e69bc41f0520_D20221001-20221231" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTA5OTUxMTY0NDExNg_5c7c25a2-918f-44bc-a090-571c4ad4a993">250,000</ix:nonFraction> per claimant. The cases allege a variety of injuries, including but not limited to multiple types of cancer, allegedly attributable to exposure to EtO. The Company does not believe these cases are appropriate for class action treatment and they have not been filed as such. The Company currently has approximately <ix:nonFraction unitRef="lawsuit" contextRef="ie90ea862d8f24e2a9ba4b91bb01f6940_D20221001-20221231" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuitsFiled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTA3ODU_e9946a78-9694-4273-9962-04a8b57f9c2a">220</ix:nonFraction> of such suits involving approximately <ix:nonFraction unitRef="plaintiff" contextRef="ie90ea862d8f24e2a9ba4b91bb01f6940_D20221001-20221231" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTA4MjY_9a8668dc-4d57-43d1-b60f-e94dcf1fee03">320</ix:nonFraction> plaintiffs; approximately <ix:nonFraction unitRef="lawsuit" contextRef="i423d5582230b485e8bfc4d66c5b13d54_D20221001-20221231" decimals="0" name="bdx:NumberOfEtOSterilizationLawsuitsAllegeInjuryFromUnrelatedDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTA5OTUxMTY0NDEyNg_9f0e60e4-5ec1-4011-8f89-3998ed42c1e8">45</ix:nonFraction> of the cases also allege injury caused by exposure to a chemical of another defendant entirely unrelated to the Company. The Company has meritorious defenses and intends to defend itself vigorously and believes that future claims would generally face statute of limitations hurdles.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. The Company believes that it has meritorious defenses to these suits pending against the Company and is engaged in a vigorous defense of each of these matters.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i94c5e489c4b3464d8cdfde5089f41e31"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict the outcome of these other legal matters discussed above, nor can it predict whether any outcome will have a material adverse effect on the Company&#8217;s consolidated results of operations and/or consolidated cash flows. Accordingly, the Company has made no provisions for these other legal matters in its consolidated results of operations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a potentially responsible party to a number of federal administrative proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as &#8220;Superfund,&#8221; and similar state laws. The Company also is subject to administrative proceedings under environmental laws in jurisdictions outside the U.S. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are underway or commencing. For several sites, there are other potentially responsible parties that may be jointly or severally liable to pay all or part of cleanup costs. While it is not feasible to predict the outcome of these proceedings, based upon the Company&#8217;s experience, current information and applicable law, the Company does not expect these proceedings to have a material adverse effect on its consolidated results of operations and/or consolidated cash flows.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation Accruals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly monitors and evaluates the status of product liability and other legal matters, and may, from time-to-time, engage in settlement and mediation discussions taking into consideration developments in the matters and the risks and uncertainties surrounding litigation. These discussions could result in settlements of one or more of these claims at any time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for the Company's product liability claims which are discussed above, as well as the related legal defense costs, amounted to approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTMyOTI_7c5fb383-2b59-4e11-93ac-470163aecde2">2.0</ix:nonFraction>&#160;billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80My9mcmFnOjFmNDM3ZmQ0MGUyNTRkMTk5MThkZWZlNTdhYTFkMmY5L3RleHRyZWdpb246MWY0MzdmZDQwZTI1NGQxOTkxOGRlZmU1N2FhMWQyZjlfMTMyOTk_a309d6dc-d2f1-46a9-8c1b-c284036d3c54">2.1</ix:nonFraction> billion on December&#160;31, 2022 and September&#160;30, 2022, respectively. These accruals, which are generally long-term in nature, are largely recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the Company's condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7cbbc1ce62ad407fbc71a490763943cb">In view of the uncertainties discussed above, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company&#8217;s consolidated results of operations, financial condition, and/or consolidated cash flows.</ix:continuation></span></div></ix:continuation><div id="i38cf244bc5b742d8ae124c6f37f53505_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMzk2MA_1b067433-f4b7-4aa8-ac61-53ca949c7b42" continuedAt="i67090652763a46419c37be359d666800" escape="true">Revenues</ix:nonNumeric></span></div><ix:continuation id="i67090652763a46419c37be359d666800" continuedAt="i01f65a24e71642eaa725cad36e7796b6"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policies for recognizing sales have not changed from those described in the Company&#8217;s 2022 Annual Report on Form 10-K. The Company sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products which are distributed through independent distribution channels and directly by BD through sales representatives. End-users of the Company's products include healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.</span></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMzk2Mg_ccc38816-8883-472c-ba7e-d460e85fa10f" continuedAt="i5cb640b7fadd4da8bc620f987047fa3f" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer-specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. The allowance for doubtful accounts for trade receivables is not material to the Company's consolidated financial results.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5cb640b7fadd4da8bc620f987047fa3f">The Company's gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts and sales returns.</ix:continuation> The Company&#8217;s rebate liability at December&#160;31, 2022 and September&#160;30, 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMTQxMg_7d25662f-383d-46d6-be23-73cf43ddccbd">560</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="bdx:ContractWithCustomerRebateLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMTQxOQ_62d714cb-ef1c-4fd8-b47b-4d453377d90c">525</ix:nonFraction>&#160;million, respectively. The impact of other forms of variable consideration, including sales discounts and sales returns, is not material to the Company's revenues.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Revenue Arrangements on Consolidated Balance Sheets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized contract costs associated with the costs to fulfill contracts for certain products in the Medication Management Solutions organizational unit are immaterial to the Company's condensed consolidated balance sheets. Commissions relating to revenues recognized over a period longer than one year are recorded as assets which are amortized over the period over which the revenues underlying the commissions are recognized. Capitalized contract costs related to such commissions are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities for unearned revenue that is allocable to performance obligations, such as extended warranty and software maintenance contracts, which are performed over time are immaterial to the Company's consolidated financial results. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i01f65a24e71642eaa725cad36e7796b6"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's liability for product warranties provided under its agreements with customers is not material to its condensed consolidated balance sheets. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's obligations relative to service contracts and pending installations of equipment, primarily in the Company's Medication Management Solutions unit, represent unsatisfied performance obligations of the Company. The revenues under existing contracts with original expected durations of more than one year, which are attributable to products and/or services that have not yet been installed or provided are estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i75c2c1904e8a4932aa21ed4530b0aa1a_I20221231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMzA4Mg_791db930-05f4-4596-95fa-bb268eead0fc">2.5</ix:nonFraction> billion at December&#160;31, 2022. The Company expects to recognize the majority of this revenue over the next <ix:nonNumeric contextRef="if55136b90ffd4da3b185ac706bad63d2_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMzE2OQ_52697cf1-67e0-445e-bd62-156dee44c074">three years</ix:nonNumeric>.  </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Company's Medication Management Solutions, Medication Delivery Solutions, Integrated Diagnostic Solutions, and Biosciences units, some contracts also contain minimum purchase commitments of reagents or other consumables, and the future sales of these consumables represent additional unsatisfied performance obligations of the Company. The revenue attributable to the unsatisfied minimum purchase commitment-related performance obligations, for contracts with original expected durations of more than one year, is estimated to be approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="if4a6e8c8f2aa4baf87dfb8f5f3c73094_I20221231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80Ni9mcmFnOjk2YWRlOGUxMWI0MjQ3MWJiZTdkMzFmOTAxYTZmNTQxL3RleHRyZWdpb246OTZhZGU4ZTExYjQyNDcxYmJlN2QzMWY5MDFhNmY1NDFfMzczMA_5f926247-0b48-4508-b581-63544a512ac6">1.9</ix:nonFraction> billion&#160;at&#160;December&#160;31, 2022.&#160;This revenue will be recognized over the customer relationship periods.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A disaggregation of the Company's revenues by segment, organizational unit and geographic region is provided in Note 7.</span></div></ix:continuation><div id="i38cf244bc5b742d8ae124c6f37f53505_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RleHRyZWdpb246YTQ2ZDhlMWUyMjQwNDMyZThlZmNkNzZlMzYyZjRhM2RfMjE2MQ_9aab821d-c4a4-4263-b464-d9e26152c7d5" continuedAt="i30e5698856f44de3a5869f997f11378c" escape="true">Segment Data</ix:nonNumeric></span></div><ix:continuation id="i30e5698856f44de3a5869f997f11378c" continuedAt="ie9a886a2e82d4dc587799d098df1a011"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's organizational structure is based upon <ix:nonFraction unitRef="segment" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RleHRyZWdpb246YTQ2ZDhlMWUyMjQwNDMyZThlZmNkNzZlMzYyZjRhM2RfODA_1794dedd-f662-4a93-a642-30b9dcb88ebf">three</ix:nonFraction> worldwide business segments: BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;). The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. Segment disclosures are on a performance basis consistent with internal management reporting. The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to its spin-off on April 1, 2022, the Company reported the Diabetes Care business as an organizational unit within the Medical segment. As such, historical financial information of the Medical segment has been recast in the tables below to reflect the total segment revenues and revenues from continuing operations. Revenues and operating income from the Diabetes Care business prior to its spin-off are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from Discontinued Operations, Net of Tax.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 2 for further information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie9a886a2e82d4dc587799d098df1a011" continuedAt="ic973831a3db94dc2b32ae1351669a095"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RleHRyZWdpb246YTQ2ZDhlMWUyMjQwNDMyZThlZmNkNzZlMzYyZjRhM2RfMjE2Nw_af402d93-6ff8-471a-9192-2d5c9cadde46" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by segment, organizational unit and geographical areas for the three-month periods are detailed below. The Company has no material intersegment revenues. </span></div><div style="margin-top:14pt;padding-left:36pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Medical</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4df7d718e44d359b01db2b4f160342_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC0xLTEtMS0xMzMwNzg_7f50b9c5-6f0a-4eb4-9a48-e4728766ae82">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecdf33e87f6543d9a3d206681b9df46c_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC0zLTEtMS0xMzMwNzg_1d6dad25-f402-4270-b10b-1c2d7b47385c">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbddb4f7cd5347e8ae58c6bb4a5ff9de_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC01LTEtMS0xMzMwNzg_8c0d36eb-c95e-463a-a810-713be2cfbbc8">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419fb7945e9e4186914030ad5cf002c4_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC03LTEtMS0xMzMwNzg_ab86760c-4e07-4f48-af45-9befeee86114">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc7802113c714a16be93a0b3b15d185e_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC05LTEtMS0xMzMwNzg_8d18b774-0977-4d69-980c-7813c5075967">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05cd70fd5ee4fa08cc226087515d4e4_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNC0xMS0xLTEtMTMzMDc4_8cf3b2c4-3404-4f9c-9bad-8f4da8415489">1,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97b220a882641bebcc06e103d5c6849_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS0xLTEtMS0xMzMwNzg_d170f9e6-2aef-426c-8b20-47f8036bc69d">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b14b1a39a84c35b2d46e8ed8e3bf66_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS0zLTEtMS0xMzMwNzg_67839403-b2ba-4106-ae2f-d0ef05f5afa9">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6dad728912d45f8b1de39a554de7d91_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS01LTEtMS0xMzMwNzg_a64fea0f-2d10-4e1d-90f3-9945ccfb1227">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427258e2d22f4014b71b90d4593f2006_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS03LTEtMS0xMzMwNzg_7b4cc036-76f3-4921-b9e9-21b4a228f5bf">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7000b865504ba4b6c647521de00044_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS05LTEtMS0xMzMwNzg_58fa06d0-017b-4ba9-a7d5-f49b2fe01ce3">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if79cb03408234abeaecac13c70082a9f_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNS0xMS0xLTEtMTMzMDc4_9004d4dc-c540-4e0c-9c67-031dd009cea9">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81124ded1d4049aa9f6c7faf5dfd6bbb_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi0xLTEtMS0xMzMwNzg_6cb575c0-b77c-479f-94be-264c88108437">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0ab9463a04da6a05cd50eb0619825_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi0zLTEtMS0xMzMwNzg_c1f11716-2ccf-4267-8086-8b6ea2511d9e">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe4b8a2b0f1456189f0184ac68cedf3_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi01LTEtMS0xMzMwNzg_910c693f-3252-4f67-ba2d-f5605fbc4e09">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a521085fe654f4cab3d93f92e803b36_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi03LTEtMS0xMzMwNzg_a287ee38-7aab-4021-a254-16b487257971">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2f7b16f0f04fbd95794034a329073b_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi05LTEtMS0xMzMwNzg_93a13df1-0821-47f3-86c7-ada26e15f10c">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2190f29165034f05b6a290e4eccfb92e_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNi0xMS0xLTEtMTMzMDc4_bcb11fd5-a373-45ca-b838-56cd42e54ea5">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1243a4869b842c48adc8550b301cf01_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy0xLTEtMS0xMzMwNzg_2ae16978-4df3-416e-81cf-afcb1f68cac4">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d40d2b45ab04d39b4c014aa23dd7677_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy0zLTEtMS0xMzMwNzg_e4edbf2f-cee1-4fe2-b637-80b6ec609911">852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a23268b072a49848e47760823d32be1_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy01LTEtMS0xMzMwNzg_036caa3b-7f54-4ad0-9008-6926c9c361f3">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbddcbed92ec45e1b99229561022e2fa_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy03LTEtMS0xMzMwNzg_e7d1f9c6-cd41-45ab-8d48-188543bfecf0">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e99aa477f4140d997e0984307d9ea6c_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy05LTEtMS0xMzMwNzg_ab56be45-a1f9-47fd-ae97-25eeeff7663c">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96262e7da19493bac51b0d6719f02a0_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfNy0xMS0xLTEtMTMzMDc4_ebd1dcd4-a004-4bb1-bcd9-edbf562a7ce0">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Life Sciences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfdf070208f6424f92129a571fcd585a_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtMS0xLTEtMTMzMDc4_ed7710de-b6d1-4397-8fad-f964c94d2d45">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21083e1dd238457db3cfd8cf7c3d4aa9_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtMy0xLTEtMTMzMDc4_86473fbe-9be5-4534-a6f7-0de1d429f461">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f70b430c7cf4b0f89e334ef902abfce_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtNS0xLTEtMTMzMDc4_f6d90698-66a0-4b98-9e9d-36ca404fdf4d">952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7688ea14dd444086bc2e5a8eab4fd009_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtNy0xLTEtMTMzMDc4_3381b9d1-2298-4c3b-8b49-13ed95c6af41">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba5dad05a914afa9c9260192569856a_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtOS0xLTEtMTMzMDc4_0dbfaf80-38e1-4a04-a81d-e496d89bd979">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37b2358ab91d45e6963d22b757222534_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTAtMTEtMS0xLTEzMzA3OA_7c0a6c4e-0255-4ead-8278-1f509cf16f52">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14ca11b98a44fe7ad9604e430feb5fe_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtMS0xLTEtMTMzMDc4_2850d446-a5e7-4baa-a291-407fdad7759f">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d157ead4f734cbc88d1e4aa43ce1907_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtMy0xLTEtMTMzMDc4_dc921235-7aa9-49b1-b3f9-a1ec1fe63eb1">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08918e7d413440588b754203e7ed36a0_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtNS0xLTEtMTMzMDc4_c5d5e622-b3db-43ad-ab1a-93e50730ef06">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21c3b59c897b48b69f6afb62798df128_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtNy0xLTEtMTMzMDc4_1d4c16a0-02d8-40f8-9642-5463762b94ff">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if298a9ecce6946209dd231654e34df0a_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtOS0xLTEtMTMzMDc4_11a1abb3-efa8-4eff-8e5e-2c83580f7335">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie377fc496c114bce896d263ee5790bb0_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTEtMTEtMS0xLTEzMzA3OA_a7dd93be-9d76-44e3-98ee-4d9a95439ea7">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b382f6205f45dc8bd42631dff1cb0e_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItMS0xLTEtMTMzMDc4_8c790b55-94d7-4355-acc0-adcbb096448d">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8e2d5e44c54ec2ad8cec1ac7310b50_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItMy0xLTEtMTMzMDc4_e93f8ef4-44d3-479d-b9dd-ae5354b81d3c">657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326b53615edc4e3590b7b892e1c86f1d_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItNS0xLTEtMTMzMDc4_af074aa2-c9e6-4b5c-8b3d-96272cd07f57">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a20ce7de413404bad0c06b89a323ef5_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItNy0xLTEtMTMzMDc4_fe061400-90b1-4e67-9cba-334667b28dd1">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd37521ebda24aafa17d8e99453a7570_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItOS0xLTEtMTMzMDc4_d5b2c7be-0bff-4af5-b425-530a9fe9c1f6">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d29b79904e043e6a527ee8b886a2d0e_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTItMTEtMS0xLTEzMzA3OA_48e68581-c33c-46e5-a1d1-2835c781883b">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Interventional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9ef13b3152443086e34967533d384a_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtMS0xLTEtMTMzMDc4_01dbf7c9-29a0-4807-a7a0-42bed14982f7">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8576e53fc144a62b019755528a08d43_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtMy0xLTEtMTMzMDc4_540c7333-2bf3-44c1-bc33-757da3a19126">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i172aa40d2a2b4f41b2036ed920b8512f_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtNS0xLTEtMTMzMDc4_b64c8941-7e67-43a6-a7fa-c353fd20a60d">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838604df1d2c4a0f94e38991fc99eb17_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtNy0xLTEtMTMzMDc4_bf6bde82-92e4-4fa8-87a4-2fc6ed80d46d">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5320c1346c45fb839be5e89c804a23_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtOS0xLTEtMTMzMDc4_02a36733-49a5-49c7-a736-c4050854ea3b">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1abd1e93bae45b3b153f0e079c9a2ac_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTUtMTEtMS0xLTEzMzA3OA_49380cd1-bacb-4007-a600-fbe887db4ba8">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie752a9a07f824cedb1b8f43363ec60cf_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtMS0xLTEtMTMzMDc4_f9a3dec0-0bf9-41e1-83c3-c3ea9ed906bd">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3e1897c2894932867cb62655e94e2a_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtMy0xLTEtMTMzMDc4_eaa6cec5-cb52-4746-9f26-eb42bd59f219">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140a53c215ce4d9a9446b24d8c351b83_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtNS0xLTEtMTMzMDc4_93856c43-433d-4dc8-a22b-2b4f05444a26">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980b8f1a884c4d418f1b99dc9234d37e_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtNy0xLTEtMTMzMDc4_a919875c-12b2-4051-98e7-c06f6fb5f9bb">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c21dbd5f1cd4f57b4dcfb3510f9173b_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtOS0xLTEtMTMzMDc4_650f76d2-61f7-4d68-bb96-ad21046a5af3">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba45e410ec3b4abc8b414ce9e5bbab7e_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTYtMTEtMS0xLTEzMzA3OA_0ff454ce-fec9-472f-9fc6-d4366b93c6ae">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c47eaa89a24c67bedc311413029cc4_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctMS0xLTEtMTMzMDc4_b66195d4-2e66-46e4-98e2-e23ac12d0f98">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cbf1ca82097469a86ff71022b72d1c1_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctMy0xLTEtMTMzMDc4_7aa977b5-1035-4b72-a54a-27b91488ebe1">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia147269082264a118964e3666eae6dd3_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctNS0xLTEtMTMzMDc4_2563a8b9-0832-469c-b086-4341da51eb95">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic939ace7836444f4a85e1082be7c9fb5_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctNy0xLTEtMTMzMDc4_f897e17c-0257-4fb0-8eec-4c8de2fda5d3">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ec502ce280485494e46ec7354af844_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctOS0xLTEtMTMzMDc4_920ec108-7360-4b91-9dbd-7fcde97b761a">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be2e175e5df492eb7e5696806ecc4b1_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTctMTEtMS0xLTEzMzA3OA_b49a255c-f5ca-40dc-87e3-d730b7be0780">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e07848af3044982a1b84a5b9d417965_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtMS0xLTEtMTMzMDc4_977ee937-1ce4-4060-8d83-b28fa92ce1c0">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29fbd4f56a4458b5c1222e0650f782_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtMy0xLTEtMTMzMDc4_b773903f-7f7b-4d2e-84a3-eedc8f3ec809">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3982372da8648c0830a8d588234c912_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtNS0xLTEtMTMzMDc4_b7343bc2-e051-43d9-a7e3-0ef01aa3519d">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9809c1deaa0e4d178d37dd3922659cd9_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtNy0xLTEtMTMzMDc4_c15f8072-5642-4df8-8068-91d4bec2a40d">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if134802de91a4c1e9adf45eec6d39718_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtOS0xLTEtMTMzMDc4_eb758b47-6480-45bd-8d2f-d564e5722dce">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c3dc6d70f04fe1b91aa9f7d059cde0_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMTgtMTEtMS0xLTEzMzA3OA_0fee5feb-50b9-417a-abdd-0f6b79b5cdbf">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c2f1baadc243f495d888202e8a4f58_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtMS0xLTEtMTMzMDc4_0cd91e97-cec2-4196-af8e-62a83dbf1ea8">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeaca528a8ce47afa8bb4982196ff70b_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtMy0xLTEtMTMzMDc4_fef247c5-b381-4b5e-a32a-350c5236c668">1,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtNS0xLTEtMTMzMDc4_922f8324-e5d4-4869-9cc0-eb113ba5f39d">4,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6771a6ac30a340b3902a56cd0cfa16b9_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtNy0xLTEtMTMzMDc4_233ca7a9-bea9-4235-980f-f3f6f0bb41e6">2,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4937715b632e4212bd6723d625df383f_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtOS0xLTEtMTMzMDc4_bda360e2-36f0-46f7-898d-16a31648e419">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOmQ1ZmYxNTc1MDU2NjRjMzA4ZWZlZGM3Y2E5ZTUzOThmL3RhYmxlcmFuZ2U6ZDVmZjE1NzUwNTY2NGMzMDhlZmVkYzdjYTllNTM5OGZfMjAtMTEtMS0xLTEzMzA3OA_aaca22a7-c35f-40b1-917a-a49a64b0da7a">4,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Certain prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.624%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RleHRyZWdpb246YTQ2ZDhlMWUyMjQwNDMyZThlZmNkNzZlMzYyZjRhM2RfMjE2OA_dcaec77f-d117-4b40-8d6d-634c0715c0d7" continuedAt="i8fb1bbc2039c474a9f5c6763d6564dfb" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income for the three-month periods was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"></td><td style="width:63.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Income from Continuing Operations Before Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a23268b072a49848e47760823d32be1_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfMy0xLTEtMS0xMzMwNzg_b29c167e-65bb-4976-a073-b82d4dbb709c">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96262e7da19493bac51b0d6719f02a0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfMy0zLTEtMS0xMzMwNzg_9b76314c-d053-4843-846d-1f62f1103e0e">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326b53615edc4e3590b7b892e1c86f1d_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNC0xLTEtMS0xMzMwNzg_2394cee6-f215-4d1f-89b0-547cc10884fc">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d29b79904e043e6a527ee8b886a2d0e_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNC0zLTEtMS0xMzMwNzg_630acd70-e73e-4c1c-ba28-2febe43afb7f">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3982372da8648c0830a8d588234c912_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNS0xLTEtMS0xMzMwNzg_8cfba368-c20f-496e-9263-83baefe90990">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c3dc6d70f04fe1b91aa9f7d059cde0_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNS0zLTEtMS0xMzMwNzg_8bc89551-7d1e-4755-a244-516029a397b0">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Segment Operating Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie940a36c0d3d45ab939535bd82ad2e05_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNi0xLTEtMS0xMzMwNzg_b75f7ea0-6060-40e8-800f-c59133318611">1,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d6ab32417c4fa6b3d23a6de66c6405_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNi0zLTEtMS0xMzMwNzg_2da56bca-dfaf-4454-ac67-b26694ceacd8">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a5a4ffa2b364d5dbe59cae615f0ef2c_D20221001-20221231" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNy0xLTEtMS0xMzMwNzg_15581525-e966-4fc6-ba14-d1a1c9725787">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d404ff6b7a4256873beee96a1c78dc_D20211001-20211231" decimals="-6" name="bdx:AcquisitionRelatedCostsAndRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfNy0zLTEtMS0xMzMwNzg_5d864380-2346-4648-b396-93fa564273b5">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a5a4ffa2b364d5dbe59cae615f0ef2c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfOC0xLTEtMS0xMzMwNzg_8f3302b9-9dce-4ae9-a120-327b0b995c6f">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04d404ff6b7a4256873beee96a1c78dc_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfOC0zLTEtMS0xMzMwNzg_ea3a1cc7-cc68-46eb-a44a-7f2fad814222">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other unallocated items (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12a8b4c0809d429f8f4e8e07487ff176_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfOS0xLTEtMS0xMzMwNzg_01d85d8c-a923-4a1c-b040-7835bc702b98">667</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09205dd95ae245c0b9245990244cbdbd_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfOS0zLTEtMS0xMzMwNzg_49b50026-dbc1-4427-8d40-c4b3f864c37a">642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Income from Continuing Operations Before Income Taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfMTAtMS0xLTEtMTMzMDc4_947793e3-1840-4536-942f-5b300085d7ad">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV80OS9mcmFnOmE0NmQ4ZTFlMjI0MDQzMmU4ZWZjZDc2ZTM2MmY0YTNkL3RhYmxlOjVlNDc0OGFlOGQ5NTQzMjk4N2QxY2EwMzkzZDg4MjlkL3RhYmxlcmFuZ2U6NWU0NzQ4YWU4ZDk1NDMyOTg3ZDFjYTAzOTNkODgyOWRfMTAtMy0xLTEtMTMzMDc4_c872fc62-7848-4d28-9722-d44d49c8354a">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic973831a3db94dc2b32ae1351669a095" continuedAt="i7586d90d03b24d39b378868fd2829773"><ix:continuation id="i8fb1bbc2039c474a9f5c6763d6564dfb" continuedAt="i02951d7d885c451591bc38a8e135b27b">(a)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"><ix:continuation id="i7586d90d03b24d39b378868fd2829773"><ix:continuation id="i02951d7d885c451591bc38a8e135b27b">Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RleHRyZWdpb246MmZjYTMyYzYzMWRhNGUyYmFhMzFlYzhlNTAwYWJhZGZfMTA0Mw_7f1ed044-296b-4d59-a417-4c22189d4389" continuedAt="ib997a888c21b4e53af451c3ad1bac701" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="ib997a888c21b4e53af451c3ad1bac701" continuedAt="i7b76771577134da0abbb12d0a4b4b2ed"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has defined benefit pension plans covering certain employees in the United States and certain international locations. The measurement date used for these plans is September&#160;30.</span></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RleHRyZWdpb246MmZjYTMyYzYzMWRhNGUyYmFhMzFlYzhlNTAwYWJhZGZfMTA0MQ_0ed3733f-6c80-4ca9-b5e5-fc299518c2b1" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net pension cost included the following components for the three-month periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:62.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.392%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfMi0xLTEtMS0xMzMwNzg_e2ddff92-7679-4386-ae86-f874d361321b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfMi0zLTEtMS0xMzMwNzg_293e954a-ab0f-491d-9183-818b2ffa396b">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfMy0xLTEtMS0xMzMwNzg_38d044c4-8343-4714-9c10-7169ed3b7fd5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfMy0zLTEtMS0xMzMwNzg_bf534b90-87e3-468b-97cf-803f88870fc5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNC0xLTEtMS0xMzMwNzg_dfb14b0b-2505-4d5e-afd5-d7d837d36217">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNC0zLTEtMS0xMzMwNzg_ff784cfe-86b2-4231-8dc3-ac274daed6bd">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNS0xLTEtMS0xMzMwNzg_6bb01d19-8e64-4dcf-a1ff-0ded1958dfbb">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNS0zLTEtMS0xMzMwNzg_43aef2de-48fe-4a9a-8f82-c5d2011745a8">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNi0xLTEtMS0xMzMwNzg_3abea772-c5c5-4492-9130-c414c966bab4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNi0zLTEtMS0xMzMwNzg_1f995ec9-c95f-4c1a-b321-51ed7bf638cc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNy0xLTEtMS0xMzMwNzg_afbcaadc-356e-471e-89f6-e066d20c4d48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfNy0zLTEtMS0xMzMwNzg_e67c0de2-e27b-4816-9749-fd3d6318f622">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if795830eab4245478ba5ff5d3835ca24_D20221001-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfOC0xLTEtMS0xMzMwNzg_a3a83056-b0cc-4100-be6b-da0e9e148717">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib086191fba114c828ee0faab4f1391be_D20211001-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81Mi9mcmFnOjJmY2EzMmM2MzFkYTRlMmJhYTMxZWM4ZTUwMGFiYWRmL3RhYmxlOjE5MDYxMjVlMmE2NjRmOTM5MWFjNjU5MzMwOGFmNmUxL3RhYmxlcmFuZ2U6MTkwNjEyNWUyYTY2NGY5MzkxYWM2NTkzMzA4YWY2ZTFfOC0zLTEtMS0xMzMwNzg_f846771d-2c0e-43ed-921b-55182301c4c1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt"><ix:continuation id="i7b76771577134da0abbb12d0a4b4b2ed" continuedAt="i08558ee2c04a49189f964f1e2af00115"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in prior periods. All components of the Company&#8217;s net periodic pension and postretirement benefit costs, aside from service cost, are recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i08558ee2c04a49189f964f1e2af00115"> on its condensed consolidated statements of income.</ix:continuation> </span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RleHRyZWdpb246Yzk5MjhmOWQ0NGM1NDY3MGE2MDIzOGIwN2I3MWEzODBfNjA4_e06dbbf8-fab1-4e99-b321-e840d2f0dfdf" continuedAt="ic43e00144c654934a60c2c83bc360632" escape="true">Business Restructuring Charges</ix:nonNumeric></span></div><ix:continuation id="ic43e00144c654934a60c2c83bc360632"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred restructuring costs during the three months ended December&#160;31, 2022, primarily in connection with the Company's simplification and other cost saving initiatives, which were recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These simplification and other costs saving initiatives are focused on reducing complexity, enhancing product quality, refining customer experience, and improving cost efficiency across all of the Company&#8217;s segments. <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RleHRyZWdpb246Yzk5MjhmOWQ0NGM1NDY3MGE2MDIzOGIwN2I3MWEzODBfNjEy_6dcbc98e-6581-4d3e-8349-a148afaa8fe5" continuedAt="i65f8c41e3f0140cf975a1c5705407725" escape="true">Restructuring liability activity for the three months ended December&#160;31, 2022 was as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i65f8c41e3f0140cf975a1c5705407725"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.456%"><tr><td style="width:1.0%"></td><td style="width:36.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee<br/>Termination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5717df6c7344c82a1f946e8cd9ad74e_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMS0xLTEtMS0xMzMwNzg_7456a7d5-27da-4ff7-9666-921101e37dbc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebfd3535ccaa4847b138a0dd86fd4aa1_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMS0zLTEtMS0xMzMwNzg_23ef6c4e-c2de-469a-93d9-0f9e9e15c307">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMS01LTEtMS0xMzMwNzg_474ec3b0-a7b8-4bc5-b016-0080f13cb1a1">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2156aabf71e74425a851790725beed31_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMy0xLTEtMS0xMzMwNzg_4551d240-0bf1-4362-9c58-6e61ba4bb342">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f7bcf9279274b6f85e75ca93ab1591c_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMy0zLTEtMS0xMzMwNzg_a2c01e84-e8ed-4fac-9ed9-367cd049f7ab">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfMy01LTEtMS0xMzMwNzg_0ed47877-e4bb-49da-8f26-91cbac26c440">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2156aabf71e74425a851790725beed31_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNC0xLTEtMS0xMzMwNzg_72fe00ac-f1b5-483c-b82c-dbe070347956">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7bcf9279274b6f85e75ca93ab1591c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNC0zLTEtMS0xMzMwNzg_dd3e6767-0bb6-4137-9a24-ea907f86c479">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNC01LTEtMS0xMzMwNzg_b6269b89-4369-420c-98c5-18534dd76a5a">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i749ac19226b4468c84f9cd4cd6a25300_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNS0xLTEtMS0xMzMwNzg_d70eac34-db4b-467f-839d-0f309d2bfcdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id18c9cbad98a4c03b8fe5f882ae9d150_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNS0zLTEtMS0xMzMwNzg_f890d58c-5dbb-4157-a22b-0d479956096f">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id49c0ff0927d43dbbde9d4540066833e_D20221001-20221231" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNS01LTEtMS0xMzMwNzg_1b488334-e7f7-4110-97eb-a9b72b20b6e4">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaadc1877da2a435d8a6a0c0647b4d3cb_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNy0xLTEtMS0xMzMwNzg_1eb045f3-eab0-4feb-86fb-f2eba5698492">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie220465732bb4f1ca36beeef4c77c632_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNy0zLTEtMS0xMzMwNzg_a8966e3c-3e91-46e1-9141-a0523f13cac8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81NS9mcmFnOmM5OTI4ZjlkNDRjNTQ2NzBhNjAyMzhiMDdiNzFhMzgwL3RhYmxlOjAyYjY4M2YxMjVjMDQ4MTA4NGI3N2JjOWMwMmU5ZmJhL3RhYmxlcmFuZ2U6MDJiNjgzZjEyNWMwNDgxMDg0Yjc3YmM5YzAyZTlmYmFfNy01LTEtMS0xMzMwNzg_f2b56a2b-3152-4a31-9d7a-f0c48bd5f98a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:3pt;text-indent:-18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RleHRyZWdpb246Mzk2Y2JlZTkxZGFmNDlhZjk3ZWJkN2E1OTc2Y2ZlMGVfNjY4_b75149a6-1a89-4f5b-9c9d-092497e8979c" continuedAt="id600065f7667475f918f4286b194eecc" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="id600065f7667475f918f4286b194eecc"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RleHRyZWdpb246Mzk2Y2JlZTkxZGFmNDlhZjk3ZWJkN2E1OTc2Y2ZlMGVfNjY5_747c6a3b-cfd8-4b3a-b05c-8c34fa1b8fa9" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-31.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ffc8c73de740999be98057b1030bbe_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy0xLTEtMS0xMzMwNzg_351d24e9-ae13-4402-857f-cac7492aed3c">15,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95ffc8c73de740999be98057b1030bbe_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy0zLTEtMS0xMzMwNzg_31899658-fbb7-4b06-8ba0-057ecee2e5be">6,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ffc8c73de740999be98057b1030bbe_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy01LTEtMS0xMzMwNzg_ff00ec18-8d66-44ff-8a5f-396c54367316">8,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaaf93142a7430daed0f30bf7b51cd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy03LTEtMS0xMzMwNzg_23c84e52-ab64-48c8-9b03-77098b63bfbf">15,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eaaf93142a7430daed0f30bf7b51cd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy05LTEtMS0xMzMwNzg_0b08f35e-45b6-4d12-8d44-ec0153a587c2">5,979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eaaf93142a7430daed0f30bf7b51cd1_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMy0xMS0xLTEtMTMzMDc4_1f1444c1-c4a0-4259-8dff-9a1b5608d898">9,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57a34902b1164c25bf2e784198077176_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC0xLTEtMS0xMzMwNzg_f9053c1d-e40d-4aee-bde2-3ff326ecc692">4,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57a34902b1164c25bf2e784198077176_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC0zLTEtMS0xMzMwNzg_ddf8d9bb-b96b-409e-b964-51e2be3a6b79">2,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57a34902b1164c25bf2e784198077176_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC01LTEtMS0xMzMwNzg_62fbe665-3fe1-4391-8827-b20b83901d72">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dabf6b5ce6447585a1293d56818d28_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC03LTEtMS0xMzMwNzg_71127e60-18ed-4505-bb09-c18750adee6f">4,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65dabf6b5ce6447585a1293d56818d28_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC05LTEtMS0xMzMwNzg_04438308-a153-4232-8d78-6ad53946161b">2,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65dabf6b5ce6447585a1293d56818d28_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNC0xMS0xLTEtMTMzMDc4_08dfb95e-a276-43a4-8295-25b05a8d2e0f">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if701fdd1cd044c79a2860c68eed8e537_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS0xLTEtMS0xMzMwNzg_fe5c76e3-bec5-4793-ba9b-571922aba9a5">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if701fdd1cd044c79a2860c68eed8e537_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS0zLTEtMS0xMzMwNzg_14167efc-8a47-4bfb-a71a-0b98e717cbd1">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if701fdd1cd044c79a2860c68eed8e537_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS01LTEtMS0xMzMwNzg_f98fa9c4-3062-4bc0-8559-13f35dc10c05">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb656747d7c400584c7fc1718ef01d6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS03LTEtMS0xMzMwNzg_66ed1a39-ed2a-49fa-9bc6-8c71ba0db014">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0fb656747d7c400584c7fc1718ef01d6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS05LTEtMS0xMzMwNzg_31569a15-1288-4071-ab9b-abd1747c1d08">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb656747d7c400584c7fc1718ef01d6_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNS0xMS0xLTEtMTMzMDc4_b3cd920b-0c9b-4011-ae3e-9648a26a38f7">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dba8a603184f7d8c6d201d00df2ac8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi0xLTEtMS0xMzMwNzg_7dbfdcb3-eadc-46c0-8957-69616eaec75b">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0dba8a603184f7d8c6d201d00df2ac8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi0zLTEtMS0xMzMwNzg_ec9fb0e6-27be-4ef7-9d96-eb001ac801de">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dba8a603184f7d8c6d201d00df2ac8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi01LTEtMS0xMzMwNzg_ee7884a0-bec1-4f37-b3bf-4e0d4a1b47c8">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba05eadaf3b404ba573df338edeb748_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi03LTEtMS0xMzMwNzg_c5d2b0ff-4951-4058-8900-83c5fdff5a24">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifba05eadaf3b404ba573df338edeb748_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi05LTEtMS0xMzMwNzg_4698d040-a806-47b8-9eff-5240429cb4a3">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba05eadaf3b404ba573df338edeb748_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNi0xMS0xLTEtMTMzMDc4_7476ba0c-e030-420f-89ca-4decb9a14abb">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b81b2651de4a3b94a8bc0ff9b71f73_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy0xLTEtMS0xMzMwNzg_172e4538-59cf-4a72-a0da-f77b52ac8fec">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b81b2651de4a3b94a8bc0ff9b71f73_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy0zLTEtMS0xMzMwNzg_0dca4420-7d46-4874-8ee8-ad584b2f0805">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b81b2651de4a3b94a8bc0ff9b71f73_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy01LTEtMS0xMzMwNzg_ced02214-ca0b-49e1-878f-82015048a0b1">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib15f8a83f2cc44dda675276a12c3561e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy03LTEtMS0xMzMwNzg_be414523-ad81-4e1e-beda-5b7a0cd91066">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib15f8a83f2cc44dda675276a12c3561e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy05LTEtMS0xMzMwNzg_621ff202-7b4d-4438-a7fd-c9b1a779f937">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib15f8a83f2cc44dda675276a12c3561e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfNy0xMS0xLTEtMTMzMDc4_6f069012-9913-4ef9-81fd-e38bcc83f3d5">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC0xLTEtMS0xMzMwNzg_4a97be80-3ce2-4a1f-ba93-0740caabeed9">21,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC0zLTEtMS0xMzMwNzg_f8108a2d-bd49-45eb-8957-4f8407074a3d">9,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC01LTEtMS0xMzMwNzg_e9af9a6c-26f1-46bd-832a-a98dac6b00c3">11,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC03LTEtMS0xMzMwNzg_c8887c37-6af6-4d3a-a70d-1207135d6ce1">20,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC05LTEtMS0xMzMwNzg_0cdf0394-8930-4446-a152-3c791567cd33">8,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfOC0xMS0xLTEtMTMzMDc4_5b37dca3-0027-4803-affd-b2f771555aad">12,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b9e895f15df46719894106cdaa09e57_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTAtMS0xLTEtMTMzMDc4_adb64065-2cf5-43ec-ab4f-dd110199f364">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1de29f9c2ff34c8997e08fa29def0869_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTAtNy0xLTEtMTMzMDc4_14db03e1-40d0-4bb0-af29-16dd3f1434b2">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic927ad46f6cb431fa4061147b4da6f75_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTEtMS0xLTEtMTMzMDc4_47eaae54-2165-4154-a0c3-02562a0ccddf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a6cda300624e4480221d59fb4362a6_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTEtNy0xLTEtMTMzMDc4_cd79982e-26d7-4950-8739-d4f322950a8b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTItMS0xLTEtMTMzMDc4_166e97ce-9595-4023-8cd6-4a4f9f9e7298">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOmVkMGU4OTI0NjE5MzRmNjZhYzE5ZGNlMzJjNzc2YWQ3L3RhYmxlcmFuZ2U6ZWQwZTg5MjQ2MTkzNGY2NmFjMTlkY2UzMmM3NzZhZDdfMTItNy0xLTEtMTMzMDc4_33b7873f-efbd-42e1-9504-78232c9cbcba">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for the three months ended&#160;December&#160;31, 2022 and 2021&#160;was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RleHRyZWdpb246Mzk2Y2JlZTkxZGFmNDlhZjk3ZWJkN2E1OTc2Y2ZlMGVfMzQ1_a671dbb4-3ed7-4dc0-9e14-dfc7a8d6b22a">365</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and $<ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RleHRyZWdpb246Mzk2Y2JlZTkxZGFmNDlhZjk3ZWJkN2E1OTc2Y2ZlMGVfMzUy_d5e06e5a-4e13-4540-9dae-9f314920c1cf">355</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RleHRyZWdpb246Mzk2Y2JlZTkxZGFmNDlhZjk3ZWJkN2E1OTc2Y2ZlMGVfNjcx_784517db-2c7a-471e-8fbc-8406bbaf33d9" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"></td><td style="width:38.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Life&#160;Sciences</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interventional</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of September&#160;30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied876dca6a11435090e382ecb0047c2e_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfMS0xLTEtMS0xMzMwNzg_b56a42cd-770b-4c2b-8893-8563423956bd">10,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b0a5a6965d424c88d7edc43c098234_I20220930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfMS0zLTEtMS0xMzMwNzg_99697878-03df-4b50-b379-bf25914fb018">888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131ce5dc88f34019b471a12d32c5d0ac_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfMS01LTEtMS0xMzMwNzg_ee9c21ef-91f3-41d8-928c-c1ee31222f2b">12,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfMS03LTEtMS0xMzMwNzg_d5cd5e2a-f83a-448d-bd2d-779abdc13308">24,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib627bb9e11964cc0bcf9b23b5addf0bc_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNC0xLTEtMS0xMzMwNzg_d9526eea-662f-462a-83d0-cf026b3ef9f2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdfa696c686470bb56c1eaefd760b03_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNC0zLTEtMS0xMzMwNzg_0982df90-71d8-480f-b1d9-937cb8ae9046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7af00fe8e742fda4175864193a2662_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNC01LTEtMS0xMzMwNzg_b554b193-0f9a-407f-ba6a-ecbc65685358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNC03LTEtMS0xMzMwNzg_eb07af34-3361-4271-99d0-d989f3f14944">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib627bb9e11964cc0bcf9b23b5addf0bc_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNS0xLTEtMS0xMzMwNzg_c5b090cc-45b6-403a-8d77-4eebd5e23b24">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdfa696c686470bb56c1eaefd760b03_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNS0zLTEtMS0xMzMwNzg_eb57c5e4-4bd7-4fbb-bde6-b293d695937e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7af00fe8e742fda4175864193a2662_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNS01LTEtMS0xMzMwNzg_963f52ae-2cad-44fe-879d-496c8281bff4">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNS03LTEtMS0xMzMwNzg_010fcb52-352d-4b53-ad52-841b0b4dbcfc">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as of December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab3e9f4ab6e4487bd8c02b13eff6ce2_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNi0xLTEtMS0xMzMwNzg_5e472b59-9e01-4fcf-84e6-4c887e1e2e13">10,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c9921bcd04b06b7ac3a1c55f10eb0_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNi0zLTEtMS0xMzMwNzg_873feb19-8cfb-4c19-9a69-0cd7315c3630">898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd0f4803b6b472e985331108c0ea22e_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNi01LTEtMS0xMzMwNzg_86b4ba55-2f3c-4d9d-91b0-c5b390f60299">12,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV81OC9mcmFnOjM5NmNiZWU5MWRhZjQ5YWY5N2ViZDdhNTk3NmNmZTBlL3RhYmxlOjRmZTJkMThkYzI3YjRmY2E4NTA0MjNjYzFkZGE1MTc4L3RhYmxlcmFuZ2U6NGZlMmQxOGRjMjdiNGZjYTg1MDQyM2NjMWRkYTUxNzhfNi03LTEtMS0xMzMwNzg_76bc30c1-a8ca-4a85-a5b5-5808bbe78510">24,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:3pt"><span><br/></span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_61"></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RleHRyZWdpb246ZjZmN2U3YWUwMzg2NGMzNWJiMjIxOGY5YTkxNWYxMDVfNjMzNg_722c120f-e0cf-457a-b1b2-3730d5592023" continuedAt="iaaf675e4cd78467da916ad0961523118" escape="true">Derivative Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="iaaf675e4cd78467da916ad0961523118" continuedAt="i02b89dbe952341069c37932ec592f0da"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RleHRyZWdpb246ZjZmN2U3YWUwMzg2NGMzNWJiMjIxOGY5YTkxNWYxMDVfNjMzOA_169edb19-0eec-44de-be5c-116878b4d7cc" continuedAt="if73c65f5398e483f88103729e52806d7" escape="true">The Company uses derivative instruments to mitigate certain exposures. The Company does not enter into derivative financial instruments for trading or speculative purposes.</ix:nonNumeric> The effects these derivative instruments and hedged items had on the Company&#8217;s balance sheets and the fair values of the derivatives outstanding at December&#160;31, 2022 and September&#160;30, 2022 were not material. The effects on the Company&#8217;s financial performance and cash flows are provided below.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts. In order to mitigate foreign currency exposure relating to its investments in certain foreign subsidiaries, the Company has hedged the currency risk associated with those investments with certain instruments, such as foreign currency-denominated debt and cross-currency swaps, which are designated as net investment hedges, as well as currency exchange contracts. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i02b89dbe952341069c37932ec592f0da" continuedAt="i278df5550b1c49eba75d1a5845b7293d"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RleHRyZWdpb246ZjZmN2U3YWUwMzg2NGMzNWJiMjIxOGY5YTkxNWYxMDVfNjMzNA_663d91c9-d8c1-4f1c-910a-d27b81b10137" continuedAt="i6a9c9d2cd2be4ac6818168fbe2e39e9c" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments as of December&#160;31, 2022 and September&#160;30, 2022 were as follows:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:36.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9915b77dd99f4aa8b4b2493a386132a4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMS0zLTEtMS0xMzMwNzg_83e89e78-667a-447a-b355-532f47cc1fbc">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d645e41c9144a5ebedd76beb21f031b_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMS01LTEtMS0xMzMwNzg_250cc298-336b-4326-8783-7732520fcadb">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75497566561742fdb200132a8c9ae4d8_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMi0zLTEtMS0xMzMwNzg_6d904441-18e9-485f-8746-4dcf5179d52a">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083801d5a90b41068cdfafd72823e70c_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMi01LTEtMS0xMzMwNzg_5d35fda0-5910-4df2-b0c1-abc1d2aa67c5">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (c)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide421ae3a479478696eca70d565bea54_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMy0zLTEtMS0xMzMwNzg_99d49503-953c-4a5f-9650-5beb599eb221">1,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892c7476eff5423691c22479ca574bf8_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOjliZWZhMjcyMDJkZDRjMTQ4NmEzMmUwMWY0MTFlMWQzL3RhYmxlcmFuZ2U6OWJlZmEyNzIwMmRkNGMxNDg2YTMyZTAxZjQxMWUxZDNfMy01LTEtMS0xMzMwNzg_d4d398bb-24e2-480e-9775-c1a337b6eebe">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in income. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments. Net amounts recognized in&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (expense) income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, during the three months ended December&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results.</span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents foreign currency-denominated long-term notes outstanding which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.  </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents cross-currency swaps which were effective as economic hedges of net investments in certain of the Company's foreign subsidiaries.</span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains or losses relating to the net investment hedges, which are attributable to changes in the foreign currencies to U.S. dollar spot exchange rates, are recorded as accumulated foreign currency translation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the termination of a net investment hedge, any net gain or loss included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relative to the investment hedge remains until the foreign subsidiary investment is disposed of or is substantially liquidated.  </span></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RleHRyZWdpb246ZjZmN2U3YWUwMzg2NGMzNWJiMjIxOGY5YTkxNWYxMDVfNjMyMA_56a63383-3578-4694-b176-8cd795adcac0" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (losses) gains recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the Company's net investment hedges for the three-month periods were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.052%"><tr><td style="width:1.0%"></td><td style="width:62.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.392%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81e17bf495a54ea99d38bfb7ee9c5d2c_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmY4NDJjOTAzMmFjZTQ5MzRiZTdjNDNlOWJiMmRjNTI5L3RhYmxlcmFuZ2U6Zjg0MmM5MDMyYWNlNDkzNGJlN2M0M2U5YmIyZGM1MjlfMi0xLTEtMS0xMzMwNzg_e637c49b-1548-466c-b3bc-d87ffd10df71">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie798f6ec2d4a4fb4b0002ebf56335797_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmY4NDJjOTAzMmFjZTQ5MzRiZTdjNDNlOWJiMmRjNTI5L3RhYmxlcmFuZ2U6Zjg0MmM5MDMyYWNlNDkzNGJlN2M0M2U5YmIyZGM1MjlfMi0zLTEtMS0xMzMwNzg_ba22d357-d701-4b34-b1f1-ff482c35ac12">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3cd1e62e0974955bb8babd05c8183f8_D20221001-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmY4NDJjOTAzMmFjZTQ5MzRiZTdjNDNlOWJiMmRjNTI5L3RhYmxlcmFuZ2U6Zjg0MmM5MDMyYWNlNDkzNGJlN2M0M2U5YmIyZGM1MjlfMy0xLTEtMS0xMzMwNzg_80efb2f3-383c-4dab-87c4-15f9811cfaf2">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica55d26ce1b34b2cb56d6cf1e7496831_D20211001-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmY4NDJjOTAzMmFjZTQ5MzRiZTdjNDNlOWJiMmRjNTI5L3RhYmxlcmFuZ2U6Zjg0MmM5MDMyYWNlNDkzNGJlN2M0M2U5YmIyZGM1MjlfMy0zLTEtMS0xMzMwNzg_9c62e8b1-e5b4-411f-8689-2f9310db7e82">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risks and Related Strategies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if73c65f5398e483f88103729e52806d7" continuedAt="id3ee2d0435b649648346ce5e064258a9">The Company uses a mix of fixed and variable rate debt to manage its interest rate exposure, and periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either cash flow or fair value hedges.</ix:continuation></span></div><div style="margin-top:9pt"><ix:continuation id="id3ee2d0435b649648346ce5e064258a9" continuedAt="i193070d56529424ebb1717d91bb4a8ea"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to those derivatives is reclassified into earnings, within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i193070d56529424ebb1717d91bb4a8ea" continuedAt="ic9acaf3e0de6443da52abee07d219310"> over the remaining life of the hedged debt.</ix:continuation> The amounts reclassified from accumulated other comprehensive income relating to cash flow hedges during the three months ended December&#160;31, 2022 and 2021, as well as the amounts expected to be reclassified within the next 12 months, are not material to the Company's consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net after-tax losses and gains recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to interest rate hedges during the three months ended December&#160;31, 2022 and 2021 were immaterial to the Company&#8217;s consolidated financial results.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic9acaf3e0de6443da52abee07d219310">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</ix:continuation> Amounts recorded during the three months ended December&#160;31, 2022 and 2021 were immaterial to the Company's consolidated financial results. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i278df5550b1c49eba75d1a5845b7293d" continuedAt="i030518c44c184c1d8f7653d6ab04eed2"><ix:continuation id="i6a9c9d2cd2be4ac6818168fbe2e39e9c" continuedAt="i613dc7da3cd94de5bbc851b8b61f6776"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the Company&#8217;s interest rate-related derivative instruments as of December&#160;31, 2022 and September&#160;30, 2022 were as follows: </span></div><div style="margin-top:3pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1397a60597fe4950b37bb5611ba6b564_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmMwODI5NjQ0OTM4NzQ4MDJiMDBhMzYwMGEwNTMyNTkwL3RhYmxlcmFuZ2U6YzA4Mjk2NDQ5Mzg3NDgwMmIwMGEzNjAwYTA1MzI1OTBfMS0zLTEtMS0xMzMwNzg_7b0c7f8e-2d46-448e-8568-4838c5a18787">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24137548876c45b7af237c728f1f860f_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmMwODI5NjQ0OTM4NzQ4MDJiMDBhMzYwMGEwNTMyNTkwL3RhYmxlcmFuZ2U6YzA4Mjk2NDQ5Mzg3NDgwMmIwMGEzNjAwYTA1MzI1OTBfMS01LTEtMS0xMzMwNzg_0e2529ac-041b-4283-9687-798db47163da">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc75edb830dc448ab8b7f3516e42fdb9_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmMwODI5NjQ0OTM4NzQ4MDJiMDBhMzYwMGEwNTMyNTkwL3RhYmxlcmFuZ2U6YzA4Mjk2NDQ5Mzg3NDgwMmIwMGEzNjAwYTA1MzI1OTBfMi0zLTEtMS0xMzMwNzg_9be92344-f6aa-4bb4-8fd3-2b9bc75ae3eb">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c12600d8fa41d588430d5d5ad988bb_I20220930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82MS9mcmFnOmY2ZjdlN2FlMDM4NjRjMzViYjIyMThmOWE5MTVmMTA1L3RhYmxlOmMwODI5NjQ0OTM4NzQ4MDJiMDBhMzYwMGEwNTMyNTkwL3RhYmxlcmFuZ2U6YzA4Mjk2NDQ5Mzg3NDgwMmIwMGEzNjAwYTA1MzI1OTBfMi01LTEtMS0xMzMwNzg_b2d39927-5594-4e8e-be70-42cb67a9d5b6">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Represents fixed-to-floating interest rate swap agreements the Company entered into to convert the interest payments on certain long-term notes from the fixed rate to a floating interest rate based on LIBOR.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i613dc7da3cd94de5bbc851b8b61f6776" continuedAt="if4b2ebcacb154c709e3ef77636d6501a">(b)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="if4b2ebcacb154c709e3ef77636d6501a">Represents interest rate derivatives entered into to mitigate exposure to interest rate risk related to future debt issuances.</ix:continuation>   </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Risk Exposures</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i030518c44c184c1d8f7653d6ab04eed2">The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. The Company's commodity derivative forward contracts at December&#160;31, 2022 and September&#160;30, 2022 were immaterial to the Company's consolidated financial results.</ix:continuation> </span></div><div><span><br/></span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA3Nw_3608cc67-46c2-40f2-beec-ed197ed4ac60" continuedAt="ie5487852f8a445ecb4f8e6255f142b20" escape="true">Financial Instruments and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ie5487852f8a445ecb4f8e6255f142b20" continuedAt="i4ad02ed295184e2b9ad9bcf01ebde8ec"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA5Nw_2aeaac5a-cdff-445c-b777-ad55bbdd702f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following reconciles cash and equivalents and restricted cash reported within the Company's condensed consolidated balance sheets at December&#160;31, 2022 and September&#160;30, 2022 to the total of these amounts shown on the Company's consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:327.75pt"><tr><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMS0xLTEtMS0xMzMwNzg_e9cabf74-7cda-469d-97db-cdfe674d277e">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMS0zLTEtMS0xMzMwNzg_bc4165bf-a381-429f-a8dd-46a62aab3794">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMi0xLTEtMS0xMzMwNzg_a835fdbb-e89b-43ad-83a1-7d526ce281aa">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMi0zLTEtMS0xMzMwNzg_1c679fd1-1ec9-42d7-99fe-e824f48a7387">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMy0xLTEtMS0xMzMwNzg_abe9eccb-3503-4702-b692-97c639553e73">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjIyOTk4ZmRjNDFiMjQ2OWE5NjkwNDc3ZWRmNWIxYWFhL3RhYmxlcmFuZ2U6MjI5OThmZGM0MWIyNDY5YTk2OTA0NzdlZGY1YjFhYWFfMy0zLTEtMS0xMzMwNzg_44cd9dbb-9b72-4bd5-86ae-dbedb3dfba02">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA3OA_6f2259b6-88e7-4343-98f3-5b6ea1d5b114" escape="true">Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.</ix:nonNumeric> <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA3Mw_bcc191f3-3385-4946-bd04-331106dcf49b" escape="true">Restricted cash consists of cash restricted from withdrawal and usage except for certain product liability matters.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA3OQ_8f47fa99-ac8e-48f0-8b1e-da04ed51f46a" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s financial instruments are as follows:</span></div><div style="margin-top:9pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.842%"><tr><td style="width:1.0%"></td><td style="width:40.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.978%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Institutional money market accounts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMS0zLTEtMS0xMzMwNzg_18e1bef4-a593-49f7-816a-a581f41906d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMS01LTEtMS0xMzMwNzg_5ba52eeb-03de-4baf-9cc6-0e0eaeb324c1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMi0zLTEtMS0xMzMwNzg_40b82aa3-77b8-4599-b2bc-df85f0c3e4c6">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="bdx:FairValueOfDebtClassifiedFromLongTermToShortTerm" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMi01LTEtMS0xMzMwNzg_ce8e6ef3-14b7-4c96-ac20-fbfbde67343a">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMy0zLTEtMS0xMzMwNzg_7e2fff0f-93ca-4f3a-9d08-a31345c977da">12,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:LoansPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjkzMTRiYWE4MjE1MzQ3OWZiZmFjM2VjYjM3OTk1MWVmL3RhYmxlcmFuZ2U6OTMxNGJhYTgyMTUzNDc5ZmJmYWMzZWNiMzc5OTUxZWZfMy01LTEtMS0xMzMwNzg_2cf20e21-6cba-4ef3-9a11-21cc5f2557a5">12,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">These financial instruments are recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the condensed consolidated balance sheets. The institutional money market accounts permit daily redemption. <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA5OQ_4578c120-d9f9-4bc5-8a9b-2890d74f9264" continuedAt="ia9248ae2342440f68506c11951a6c535" escape="true">The fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions.</ix:nonNumeric> </span></div><div style="margin-top:3pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="ia9248ae2342440f68506c11951a6c535" continuedAt="iab8dba43f2ed4cddb9b387224aef3f89">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments.</ix:continuation></span></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab8dba43f2ed4cddb9b387224aef3f89">Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The short-term investments consist of instruments with maturities greater than <ix:nonNumeric contextRef="i678e469a5f2543ae9a3e6b53fe928e8e_D20221001-20221231" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMTI2Mw_a9ec8ab6-fe11-4142-a0e8-b18e7795bd4b">three months</ix:nonNumeric> and less than <ix:nonNumeric contextRef="id705fc88d8bd40e1995f5e9787b2584c_D20221001-20221231" name="bdx:MaturityPeriodOfShortTermInvestment" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMTI4MA_1d2b1a33-7b76-4898-bf6b-8ac5ab17cf33">one year</ix:nonNumeric>.</ix:continuation> All other instruments measured by the Company at fair value, including derivatives and contingent consideration liabilities, are immaterial to the Company's condensed consolidated balance sheets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transfers of trade receivables</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the normal course of its business activities, the Company transfers certain trade receivable assets to third parties under factoring agreements. Per the terms of these agreements, the Company surrenders control over its trade receivables upon transfer.&#160;Accordingly, the Company accounts for the transfers as sales of trade receivables by recognizing an increase to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when proceeds from the transactions are received.&#160;The costs incurred </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4ad02ed295184e2b9ad9bcf01ebde8ec" continuedAt="i72005185f2fe46d0868c34daa4cea158"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by the Company in connection with factoring activities were not material to its consolidated financial results. <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RleHRyZWdpb246OTg3OTkxMjY2ZjE2NGViMDgyNjI4ZGQ5MzUzZDFkODhfMzA5MQ_d3c22030-6bec-4433-879a-d776c5f0d388" continuedAt="i58cddf46607247d1ac491f9a57b6a41e" escape="true">The amounts transferred and yet to be remitted under factoring arrangements are provided below.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i58cddf46607247d1ac491f9a57b6a41e" continuedAt="i0ae8b944cf9c48e99e41ab11473dd361"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:56.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.568%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables transferred to third parties under factoring arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjk1OTczYTBhZGYxYzRiMmY4NDIwNGI3MjcxY2Q5NTA3L3RhYmxlcmFuZ2U6OTU5NzNhMGFkZjFjNGIyZjg0MjA0YjcyNzFjZDk1MDdfMi0xLTEtMS0xMzMwNzg_cc5d1e63-1c33-435b-8a42-57b0d1b5ee1a">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="-6" name="bdx:TransfersOfFinancialAssetsDuringThePeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjk1OTczYTBhZGYxYzRiMmY4NDIwNGI3MjcxY2Q5NTA3L3RhYmxlcmFuZ2U6OTU5NzNhMGFkZjFjNGIyZjg0MjA0YjcyNzFjZDk1MDdfMi0zLTEtMS0xMzMwNzg_1cae34c0-2f51-4770-b98e-8e7092db0e8e">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><ix:continuation id="i72005185f2fe46d0868c34daa4cea158"><ix:continuation id="i0ae8b944cf9c48e99e41ab11473dd361"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:56.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts yet to be collected and remitted to the third parties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f3e29d418945a5afade694a98ce9e8_I20221231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjgyYjdiODU5Yjg2MjQ3NjM5ZDIyOGExNjExMWEyOTY0L3RhYmxlcmFuZ2U6ODJiN2I4NTliODYyNDc2MzlkMjI4YTE2MTExYTI5NjRfMS0xLTEtMS0xMzMwNzg_ad008ab7-5598-47f9-9b96-3b73ba8c8c8f">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if076e3d476f44ea2bb4e8b2d15cf921e_I20220930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV82NC9mcmFnOjk4Nzk5MTI2NmYxNjRlYjA4MjYyOGRkOTM1M2QxZDg4L3RhYmxlOjgyYjdiODU5Yjg2MjQ3NjM5ZDIyOGExNjExMWEyOTY0L3RhYmxlcmFuZ2U6ODJiN2I4NTliODYyNDc2MzlkMjI4YTE2MTExYTI5NjRfMS0zLTEtMS0xMzMwNzg_2ea4004d-1911-4942-9625-627d56725f68">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_874"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 - <ix:nonNumeric contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV84NzQvZnJhZzpkNWM4N2Q0MmEzYWI0YTE4YjFiMTJlMGIwYTliMDEwMy90ZXh0cmVnaW9uOmQ1Yzg3ZDQyYTNhYjRhMThiMWIxMmUwYjBhOWIwMTAzXzEwOTk1MTE2MjgyOTc_d4764240-353f-462e-99ca-c946b18a05e0" continuedAt="ic77a5430af9746cd8503d58a933ca843" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic77a5430af9746cd8503d58a933ca843"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Tax Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s effective income tax rates for the three months ended December&#160;31, 2022 and 2021 were (<ix:nonFraction unitRef="number" contextRef="i3dd2e6cbe8134c8ca1768e8e14d35b1c_D20221001-20221231" decimals="INF" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV84NzQvZnJhZzpkNWM4N2Q0MmEzYWI0YTE4YjFiMTJlMGIwYTliMDEwMy90ZXh0cmVnaW9uOmQ1Yzg3ZDQyYTNhYjRhMThiMWIxMmUwYjBhOWIwMTAzXzEwOTk1MTE2MjgzMDI_eb4536d7-4443-406d-bff4-6fd6d32a5e04">5.8</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i7b883529107040e38066036197ccb84a_D20211001-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4Y2YyNDRiYzViNzQyZDhhZTEyNGM2ZjM3ZjUzNTA1L3NlYzozOGNmMjQ0YmM1Yjc0MmQ4YWUxMjRjNmYzN2Y1MzUwNV84NzQvZnJhZzpkNWM4N2Q0MmEzYWI0YTE4YjFiMTJlMGIwYTliMDEwMy90ZXh0cmVnaW9uOmQ1Yzg3ZDQyYTNhYjRhMThiMWIxMmUwYjBhOWIwMTAzXzEwOTk1MTE2MjgzMDY_5e26a3a9-dbb8-43a2-a9b4-8110ace85e55">5.3</ix:nonFraction>%, respectively. The decrease in the Company&#8217;s effective tax rate for the three months ended December&#160;31, 2022 was largely due to a remeasurement of deferred tax assets and liabilities upon the approval of a tax incentive.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following commentary should be read in conjunction with the condensed consolidated financial statements and accompanying notes presented in this report.  Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes.  Percentages and earnings per share amounts presented are calculated from the underlying amounts.  References to years throughout this discussion relate to our fiscal years, which end on September 30.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Becton, Dickinson and Company (&#8220;BD&#8221;) is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's organizational structure is based upon three principal business segments, BD Medical (&#8220;Medical&#8221;), BD Life Sciences (&#8220;Life Sciences&#8221;) and BD Interventional (&#8220;Interventional&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: EMEA (which includes Europe, the Middle East and Africa); Greater Asia (which includes countries in Greater China, Japan, South Asia, Southeast Asia, Korea, Australia and New Zealand); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and certain countries within Greater Asia. We are primarily focused on certain countries whose healthcare systems are expanding. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BD&#8217;s Spin-Off of Diabetes Care</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, BD completed the separation and distribution of Embecta, formerly BD's Diabetes Care business, into a separate, publicly-traded company.  The historical results of the Diabetes Care business (previously included in BD&#8217;s Medical segment), as well as interest expense related to indebtedness incurred by Embecta prior to the spin-off date, have been reflected as discontinued operations in our condensed consolidated financial statements for the three months ended December 31, 2021.  Additional disclosures regarding our spin-off of the Diabetes Care business are provided in Note 2 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Trends Affecting Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our BD 2025 strategy for growth is anchored in three pillars: grow, simplify and empower. As we execute this strategy, we continue to invest in research and development, strategic tuck-in acquisitions, geographic expansion, and new product programs to drive further revenue and profit growth. Our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, as well as continue to improve operating efficiency and organizational effectiveness, despite continued challenges posed by the global macroeconomic environment.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, supply chain and suppliers are exposed to various global macroeconomic factors. The factors which were most impactful to our results in the first quarter of fiscal year 2023 included the following: </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inflation, which has continued to drive higher costs of raw materials, electronic components, labor, energy, and logistical services; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Availability of skilled labor in certain markets, global energy sources, certain raw materials and electronic components; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Logistics capacity constraints which have eased compared to our fiscal year 2022, but which are still delaying the movement of goods around the globe.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has contributed to the macroeconomic conditions discussed above and certain pandemic-related impacts were experienced by our businesses during the first quarter of fiscal year 2023, as discussed in greater detail below. Future resurgences in COVID-19 infections or other new viral outbreaks may affect the prioritization of non-acute versus acute healthcare utilization, which may temporarily weaken future demand for certain of our products and increase the demand for other of our products. Additionally, the adverse macroeconomic conditions noted above may worsen if governments impose future restrictions, such as lockdowns or quarantine requirements, in order to control infection rates associated with COVID-19 or other viruses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the pandemic escalated challenges that existed for global healthcare systems prior to the pandemic, including budget constraints and staffing shortages, particularly shortages of nursing staff. Changes in the ways healthcare services are delivered, including the transition of more care from acute to non-acute settings and increased focus on chronic disease management, may place additional financial pressure on hospitals and the broader healthcare system. Healthcare institutions may take actions to mitigate any persistent pressures on their budgets and such actions could impact the future demand for our products and services. Additionally, staffing shortages within healthcare systems may affect the prioritization of healthcare services, which could also impact the demand for certain of our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain geopolitical conditions, including the conflict between Russia and Ukraine, have also contributed to the macroeconomic conditions discussed above. This conflict has not materially impacted our results of operations to date; however, the continuation of the Russia-Ukraine military conflict and/or an escalation of the conflict beyond its current scope may further weaken the global economy and could result in additional inflationary pressures and supply chain constraints, including the unavailability and cost of energy. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been mitigating the impacts of the macroeconomic factors discussed above through various strategies which leverage our procurement, logistics and manufacturing capabilities.  However, there can be no assurance that we will be able to effectively mitigate these pressures in future periods and an inability to offset these pressures, at least in part, through the strategies discussed above could adversely impact our results of operations.  Due to the significant uncertainty that exists relative to the duration and overall impact of the macroeconomic factors discussed above, our future operating performance, particularly in the short-term, may be subject to volatility. The impacts of macroeconomic conditions on our business, results of operations, financial condition and cash flows are dependent on certain factors, including those discussed in Part I, Item&#160;1A. Risk Factors of our 2022 Annual Report on Form 10-K (the &#8220;2022 Annual Report&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Financial Results and Financial Condition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December&#160;31, 2022, worldwide revenues of $4.586 billion decreased 2.8% from the prior-year period. This decrease reflected the following impacts:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:71.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.758%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease) in current-period revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in revenues related to COVID-19-only testing </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pricing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in revenues from the prior-year period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Overall volume growth was attributable to our recent acquisitions, and to a lesser extent, strong demand for products in certain of our units. Growth attributable to demand was particularly strong within the Medical segment&#8217;s Medication Management Solutions and Pharmaceutical Systems units, as well as in the Life Sciences segment&#8217;s Biosciences unit and the Interventional segment&#8217;s Peripheral Intervention unit.  See the &#8220;Results of Continuing Operations&#8221; section below for further discussion of our segments&#8217; first quarter fiscal year 2023 results. Our first quarter fiscal year 2023 revenues reflected sales related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Systems of $32 million, compared with revenues from testing products in the prior-year period of $185 million.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities were&#160;$399 million&#160;in the first three months of fiscal year 2023.  At December&#160;31, 2022, we had $744 million in cash and equivalents and short-term investments, including restricted cash.  We continued to return value to our shareholders in the form of dividends.  During the first three months of fiscal year 2023, we paid cash dividends of $281 million, including $259 million paid to common shareholders and $23 million paid to preferred shareholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each reporting period, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of such period.  A stronger U.S. dollar, compared to the prior-year period, resulted in an unfavorable foreign currency translation impact to our revenues and earnings during the first quarter of fiscal year 2023.  We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the impact of fluctuations in foreign currency exchange rates. As exchange rates are an important factor in understanding period-to-period comparisons, we believe the presentation of results on a foreign currency-neutral basis in addition to reported results helps improve investors&#8217; ability to understand our operating results and evaluate our performance in comparison to prior periods. Foreign currency-neutral ("FXN") information compares results between periods as if exchange rates had remained constant period-over-period. We use results on a foreign currency-neutral basis as one measure to evaluate our performance. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior-period foreign currency exchange rates and comparing these adjusted amounts to our current-period results. These results </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">should be considered in addition to, not as a substitute for, results reported in accordance with U.S. generally accepted accounting principles ("GAAP"). Results on a foreign currency-neutral basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with U.S. GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Continuing Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes first quarter Medical revenues by organizational unit:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery Solutions (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Management Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Systems (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Prior-period amounts were recast to reflect former intercompany transactions with Embecta.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Medical segment&#8217;s revenue growth in the first quarter of 2023 primarily reflected the following:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An unfavorable comparison of the Medication Delivery Solutions unit&#8217;s first quarter 2023 revenues to prior-period revenues, which benefited from COVID-19 dynamics, including COVID-19 vaccine-related sales, as well as the unfavorable impact of current-period COVID-19-related restrictions in China; these unfavorable impacts to first quarter 2023 revenues were partially offset by the unit&#8217;s strong international sales of catheters and vascular care products.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strong performance of the Medication Management Solutions unit&#8217;s pharmacy automation solutions, including the Parata Systems portfolio, which we acquired in fiscal year 2022, and our BD Rowa&#8482; technologies; this growth was partially offset by an unfavorable comparison to the prior-year period, which benefited from a pandemic-related increase in dispensing equipment installations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Continued strong demand for the Pharmaceutical Systems unit&#8217;s prefillable solutions in the high-growth markets for biologic drugs and vaccines.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical segment income for the three-month periods is provided below. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.561%"><tr><td style="width:1.0%"></td><td style="width:65.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.215%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Medical revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical segment's lower income in the first quarter of 2023 compared with the first quarter of 2022 reflected the following:   </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower gross profit margin in the first quarter of 2023 compared with the first quarter of 2022, which primarily reflected:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Higher raw material, labor and freight costs, partially offset by</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Lower manufacturing costs resulting from continuous improvement projects which enhanced the efficiency of our operations, as well as favorable impacts from pricing and foreign currency translation. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Higher selling and administrative expense as a percentage of revenues in the first quarter of 2023 compared with the first quarter of 2022 primarily reflected higher shipping costs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense as a percentage of revenues which was flat in the first quarter of 2023 compared with the first quarter of 2022 due to the timing of project spending.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Life Sciences Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes first quarter Life Sciences revenues by organizational unit:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:39.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.671%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Diagnostic Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biosciences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed above, the Integrated Diagnostic Solutions unit&#8217;s revenues related to COVID-19-only diagnostic testing on the BD Veritor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Plus and BD Max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Systems in the first quarter of 2023 were $32 million compared with revenues of $185 million in the prior-year period. The Life Sciences segment&#8217;s revenues in the first quarter of 2023 also reflected the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Growth driven by the Integrated Diagnostic Solutions unit&#8217;s installations of BD Kiestra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> lab automation systems, continued leverage of the unit&#8217;s larger installed base of BD MAX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> instruments and strong demand for our combination flu/COVID-19 assays was partially offset by an unfavorable comparison to the unit&#8217;s prior-period revenues, which benefited from licensing revenue.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Strong demand for the Biosciences unit&#8217;s research reagents and the unit&#8217;s recently launched flow cytometry instruments.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:43.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.425%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Life Sciences segment income for the three-month periods is provided below.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.415%"><tr><td style="width:1.0%"></td><td style="width:65.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.243%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Life Sciences revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Life Sciences segment's lower income in the first quarter of 2023 compared with the first quarter of 2022 primarily reflected the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower gross profit margin in the first quarter of 2023 compared with the first quarter of 2022, which primarily reflected the current-period declines in revenues which were attributable to COVID-19-only diagnostic testing and licensing arrangements, as noted above.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Higher selling and administrative expense, as well as research and development expense, as percentages of revenues in the first quarter of 2023 compared with the first quarter of 2022, which primarily reflected the current-period decline in revenues.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes first quarter Interventional revenues by organizational unit:</span></div><div style="margin-bottom:6pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:36.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.481%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Intervention</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interventional Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Interventional segment&#8217;s revenue growth in the first quarter of 2023 primarily reflected the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Strong global sales of the Surgery unit&#8217;s advanced repair and reconstruction platforms and double-digit growth in sales of the unit&#8217;s biosurgery products, which was aided by the unit&#8217;s fiscal year 2022 acquisition of Tissuemed, Ltd.; this growth was partially offset by planned product discontinuations and an unfavorable comparison to the prior-year period&#8217;s revenues, which benefited from dealer stocking.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The relaunch of the Peripheral Intervention unit&#8217;s Venovo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> system, global market penetration of the Rotarex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> system and growth attributable to the unit&#8217;s fiscal year 2022 acquisition of Venclose, Inc.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Strong demand for the Urology and Critical Care unit&#8217;s Purewick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">offerings in the acute and alternative care settings that was partially offset by an unfavorable comparison to the unit&#8217;s prior-period revenues, which benefited from a backorder release and distributor stocking.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interventional segment income for the three-month periods is provided below.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.561%"><tr><td style="width:1.0%"></td><td style="width:65.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.215%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Segment income as % of Interventional revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interventional segment's higher income in the first quarter of 2023 compared with the first quarter of 2022 reflected the following:  </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Higher gross profit margin in the first quarter of 2023 compared with the first quarter of 2022 was primarily driven by pricing and a favorable comparison to the prior-year period, which was unfavorably impacted by certain purchase accounting adjustments recorded by the segment.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Lower selling and administrative expense, as well as research and development expense, as percentages of revenues in the first quarter of 2023 compared with the first quarter of 2022, as the increase in current-period revenues outpaced spending.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BD&#8217;s worldwide first quarter revenues by geography were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:24.054%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,718&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenue growth in the first quarter of 2023 reflected strong sales in the Medical segment&#8217;s Medication Management Solutions and Pharmaceutical Systems units, as well as strong sales in the Interventional segment&#8217;s Peripheral Intervention unit.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First quarter U.S. revenues were unfavorably impacted by a decline in COVID-19-only diagnostic testing sales compared with the prior-year period, as discussed further above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenue growth in the first quarter of 2023 reflected strong sales in the Medical segment&#8217;s Medication Management Solutions and Pharmaceutical Systems units, as well as strong sales in the Life Sciences segment&#8217;s Biosciences unit and the Interventional segment&#8217;s Peripheral Intervention unit.  First quarter International revenues were unfavorably impacted by a decline in COVID-19-only diagnostic testing sales compared with the prior-year period, as discussed further above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging market revenues were as follows and primarily reflected growth in certain countries within Latin America, South Asia, the Middle East and Africa, partially offset by a decline in China due to pandemic-related restrictions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:34.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>FX<br/>Impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FXN Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Specified Items</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reflected in the financial results for the three-month periods of fiscal years 2023 and 2022 were the following specified items:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"></td><td style="width:69.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.220%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration costs (a)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring costs (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation-related items (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments (c)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European regulatory initiative-related costs (d)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product, litigation, and other items (e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total specified items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: tax impact of specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax impact of specified items</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents amounts associated with integration and restructuring activities which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are further discussed below.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs recorded to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other operating expense (income), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and incurred in connection with the separation of BD's former Diabetes Care business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes amortization and other adjustments related to the purchase accounting for acquisitions.  BD&#8217;s amortization expense is recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and/or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes certain (income) expense items which are not part of ordinary operations and affect the comparability of the periods presented. Such items may include certain product remediation costs, certain product liability and legal defense costs, certain investment gains and losses, and certain asset impairment charges.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit Margin</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the three-month period of fiscal year 2023 compared with the prior-year period in fiscal year 2022 reflected the following impacts:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:76.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.123%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three-month period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021 gross profit margin % </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of purchase accounting adjustments and other specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period-over-period decline in COVID-19-only testing profitability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating performance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022 gross profit margin %</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating performance in the three-month period of 2023 primarily reflected:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Higher raw material, labor and freight costs, as well as an unfavorable comparison to the prior-year period margin, which benefited from licensing revenue and a higher contribution to margin from COVID-19-only diagnostic testing revenues.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Favorable offsets which were driven by lower manufacturing costs resulting from our ongoing continuous improvement projects and pricing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating expenses for the three-month periods of fiscal years 2023 and 2022 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.298%"><tr><td style="width:1.0%"></td><td style="width:56.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.350%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in basis points</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration and restructuring expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Selling and administrative expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher selling and administrative expense as a percentage of revenues in the three-month period of 2023 compared with the prior-year period primarily reflected the current-period decline in revenues, as well as higher shipping and selling costs in the current-year period, partially offset by favorable foreign currency translation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Research and development expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense as a percentage of revenues in the three-month period of 2023 was relatively flat compared with the prior-year period, which primarily reflected the timing of project spending. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisition-related integration and restructuring expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition-related integration and restructuring expense in the three-month periods of 2023 and 2022 included restructuring costs related to simplification and other cost saving initiatives, as well as system integration costs. For further disclosures regarding restructuring costs, refer to Note 9 in the Notes to Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nonoperating Income</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Net interest expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components for the three-month periods of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.233%"><tr><td style="width:1.0%"></td><td style="width:57.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.561%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher interest expense for the three-month period of fiscal year 2023 compared with the prior-year period was largely attributable to the level of commercial paper borrowings outstanding in the current-year period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rates for continuing operations for the three-month periods of fiscal years 2023 and 2022 are provided below.  </span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.649%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.627%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate for continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impact, in basis points, from specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(590)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective income tax rate for the three-month period of fiscal year 2023 compared with the prior-year period primarily reflected the impact of a remeasurement of deferred tax assets and liabilities upon the approval of a tax incentive, as well as a tax impact from specified items that was more favorable compared with the benefit associated with specified items recognized in the prior-year period.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income and Diluted Earnings per Share from Continuing Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income and diluted earnings per share from continuing operations for the three-month periods of fiscal years 2023 and 2022 were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.514%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.393%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income from Continuing Operations (Millions of dollars)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings per Share from Continuing Operations</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.90&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-specified items</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unfavorable impact-foreign currency translation</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:1pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our condensed consolidated statements of cash flows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:70.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used for) continuing operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in the first three months of fiscal year 2023 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash.  This net use of cash primarily reflected higher levels of inventory, prepaid expenses and trade receivables, as well as lower levels of accounts payable and accrued expenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from continuing operating activities in the first three months of fiscal year 2022 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash. This net use of cash primarily reflected lower levels of accounts payable and accrued expenses and higher levels of inventory, partially offset by lower levels of trade receivables and prepaid expenses.  Cash flows from continuing operating activities in 2022 additionally reflected a discretionary cash contribution of $134 million to fund our pension obligation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, as well as support our BD 2025 strategy for growth and simplification.&#160;Net outflows from continuing investing activities in the first three months of fiscal year 2023 included capital expenditure-related outflows of $208 million, compared with $183 million in the prior-year period. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Continuing Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash from continuing financing activities in the first three months of fiscal years 2023 and 2022 included the following significant cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.163%"><tr><td style="width:1.0%"></td><td style="width:62.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash inflow (outflow)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in short-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain measures relating to our total debt were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:63.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(Millions of dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,065&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt as a percentage of total capital*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Represents shareholders&#8217; equity, net non-current deferred income tax liabilities, and debt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Short-Term Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, total worldwide cash and equivalents and short-term investments, including restricted cash, were approximately $744 million. These assets were largely held outside the United States. We regularly review the amount of cash and short-term investments held outside of the United States and our historical foreign earnings are used to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. To fund cash needs in the United States, we rely on ongoing cash flow from U.S. operations, access to capital markets and remittances from foreign subsidiaries of earnings that are not considered to be permanently reinvested. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a five-year senior unsecured revolving credit facility in place which will expire in September 2026.  The credit facility provides borrowings of up to $2.75 billion, with separate sub-limits of $100 million for letters of credit and swingline loans.  The expiration date of the credit facility may be extended for up to two additional one year periods, subject to certain restrictions (including the consent of the lenders). The credit facility provides that we may, subject to additional commitments by lenders, request an additional $500 million of financing, for a maximum aggregate commitment under the credit facility of up to $3.25 billion. Proceeds from this facility may be used for general corporate purposes. There were no borrowings outstanding under the revolving credit facility at December&#160;31, 2022.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement for our revolving credit facility contains the following financial covenants.  We were in compliance with these covenants, as applicable, as of December&#160;31, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are required to have a leverage coverage ratio of no more than:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.25-to-1 as of the last day of each fiscal quarter following the closing of the credit facility; or</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">4.75-to-1 for the four full fiscal quarters following the consummation of a material acquisition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have informal lines of credit outside the United States. We may, from time to time, access the commercial paper market as we manage working capital over the normal course of our business activities.  We had $595 million of commercial paper borrowings outstanding as of December&#160;31, 2022. Also, over the normal course of our business activities, we transfer certain trade receivable assets to third parties under factoring agreements.  Additional disclosures regarding sales of trade receivable assets are provided in Note 12 in the Notes to Condensed Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access to Capital and Credit Ratings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate credit ratings with Standard &amp; Poor's Ratings Services, Moody&#8217;s Investors Service and Fitch Ratings at December&#160;31, 2022 were unchanged compared with our ratings at September&#160;30, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lower corporate debt ratings and downgrades of our corporate credit ratings or other credit ratings may increase our cost of borrowing.  We believe that given our debt ratings, our financial management policies, our ability to generate cash flow and the non-cyclical, geographically diversified nature of our businesses, we would have access to additional short-term and long-term capital should the need arise.  A rating reflects only the view of a rating agency and is not a recommendation to buy, sell or hold securities.  Ratings can be revised upward or downward at any time by a rating agency if such rating agency decides that circumstances warrant such a change.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually evaluate our accounts receivables for potential credit losses, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries&#8217; national economies. In addition to continually evaluating all governmental receivables for potential credit losses based upon historical loss experiences, we also evaluate such receivables based upon the availability of government funding and reimbursement practices. We believe the current reserves related to all </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental receivables are adequate and that these receivables will not have a material adverse impact on our financial position or liquidity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not experienced a significant increased risk of credit losses in general as a result of current macroeconomic conditions.  No assurances can be given that the risk of credit losses will not increase in the future given the uncertainty around the duration of the current macroeconomic challenges and pressures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to our critical accounting policies from those disclosed in our 2022 Annual Report.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">FDA Warning Letter</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2018, BD received a Warning Letter from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) with respect to our former BD Preanalytical Systems ("PAS") unit, citing certain alleged violations of quality system regulations and of law. The Warning Letter states that, until BD resolves the outstanding issues covered by the Warning Letter, the FDA will not approve any premarket submissions for Class III devices to which the non-conformances are reasonably related or grant requests for certificates to foreign governments. BD has worked closely with the FDA and implemented corrective actions to address the quality management system concerns identified in the Warning Letter.  In March 2020, the FDA conducted a subsequent inspection of PAS, which it classified as Voluntary Action Indicated, which means the FDA will not take or recommend any administrative or regulatory action as a result of the unit&#8217;s response to the observations associated with the quality management concerns in the inspection. BD continues to work with the FDA to generate additional clinical evidence and file 510(k)s as remaining commitments associated with the Warning Letter. In January 2022, BD received FDA clearance for its BD Vacutainer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ACD Blood Collection Tubes used in immunohematology. The FDA review of these remaining commitments is ongoing, and no assurances can be given regarding further action by the FDA as a result of these commitments, including but not limited to action pursuant to the Warning Letter.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Ethylene Oxide/Consent Order &#8212; Covington, Georgia, USA</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2019, BD entered into a consent order with the Environmental Protection Division of the Georgia Department of Natural Resources (the &#8220;EPD&#8221;), following the filing of a complaint and motion for temporary restraining order by the EPD seeking to enjoin BD from continuing sterilization operations at its Covington, Georgia facility.  Under the terms of the consent order,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which has been amended two times upon mutual agreement of BD and EPD, BD voluntarily agreed to a nu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mber of operational changes at its Covington and Madison, Georgia facilities, as well as at its distribution center in Covington, designed to further reduce ethylene oxide emissions, including but not limited to operating at a reduced capacity until successful implementation of fugitive emission control technology, ongoing ambient air monitoring and operational controls at such facilities. Following submission of data relating to the implementation of these operational changes, BD was permitted to return to normal operations in December 2021 at its facilities in Georgia in accordance with the operating conditions set forth in its permit applications, including a condition to continue ambient air monitoring. However, BD&#8217;s sterilization operations in Georgia remain subject to the EPD&#8217;s final approval of BD&#8217;s air permit applications and could be subject to additional restrictions.  BD has business continuity plans in place to mitigate the impact of any additional restrictions on our operations at these facilities, although it is possible that these plans will not be able to fully offset such impact, especially considering the reduced capacity of third-party sterilization service providers and the regulatory timelines associated with transferring sterilization operations for regulated products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At a broader level, there is increased focus on the use and emission of ethylene oxide by the U.S. Environmental Protection Agency and state environmental regulatory agencies. Additional regulatory requirements associated with the use and emission of ethylene oxide may be imposed in the future, either domestically or outside the U.S. Ethylene oxide is the most frequently used sterilant for medical devices and healthcare products in the U.S., and in certain cases is the only option to sterilize critical medical device products for the safe administration to patients. This increased regulation could require BD or sterilization service providers, including providers used by BD, to temporarily suspend operations to install additional fugitive emissions control technology, limit the use of ethylene oxide or take other actions, which would impact BD&#8217;s operations and further reduce the available capacity to sterilize medical devices and healthcare products, and could also result in additional costs. A few states have filed lawsuits to require additional air quality controls and expand limitations on the use of ethylene oxide at sterilization facilities. For example, in December 2020, the State of New Mexico filed a lawsuit seeking a temporary restraining order and a preliminary and permanent injunction against a major medical device sterilizer, which sterilizes certain of our surgery products, to reduce ethylene oxide emissions associated with their sterilization process. On the federal level, in late 2019, the U.S. Environmental Protection Agency provided notice that it would be conducting rulemaking to reconsider federal regulations applicable to the use and emission of ethylene oxide, and there continues to be increased focus on the use and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">emission of ethylene oxide on the federal level. In anticipation of these proposed revisions to federal air regulations for commercial sterilizers in the U.S., BD is installing fugitive emissions controls at our facilities in East Columbus, NE and Sandy, UT.  It is possible that there may also be increased regulation outside the U.S.  If any existing regulatory requirements or any such proceedings or rulemaking result in the suspension or interruption of sterilization operations at BD or at medical device sterilizers used by BD, or otherwise limit the availability of third-party sterilization capacity, this could interrupt or otherwise adversely impact production of certain of our products or lead to civil litigation or other claims against BD. BD has business continuity plans in place to mitigate the impact of any such disruptions, although these plans may not be able to fully offset such impact, for the reasons noted above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Decree with FDA</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pump organizational unit is operating under an amended consent decree entered into by CareFusion (the &#8220;Consent Decree&#8221;) that includes all infusion pumps manufactured by or for CareFusion 303, Inc., the organizational unit that manufactures and sells Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infusion pumps in the United States.&#160; </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following an inspection that began in March 2020 of our Medication Management Systems facility (CareFusion 303, Inc.) in San Diego, California, the FDA issued to BD a Form 483 Notice (the &#8220;Form 483 Notice&#8221;) that contains a number of observations of non-conformance with the FDA&#8217;s quality system regulations. In December 2021, the FDA issued to CareFusion 303, Inc. a letter of non-compliance with respect to the Consent Decree (the &#8220;Non-Compliance Letter&#8221;) stating that, among other things, it had determined that certain of BD&#8217;s corrective actions with respect to the Form 483 Notice appeared to be adequate, some were still in progress such that adequacy could not be determined yet, and certain others were not adequate (e.g., complaint handling and corrective and preventive actions (&#8220;CAPA&#8221;), design verification and medical device reporting). Per the terms of the Non-Compliance Letter, CareFusion 303, Inc. provided the FDA with a proposed comprehensive corrective action plan and has retained an independent expert to conduct periodic audits of the CareFusion 303, Inc. infusion pump facilities over the next four years. CareFusion 303, Inc. will update its corrective action plan to address any observations that may arise during the course of these audits. The FDA&#8217;s review of the items raised in the Form 483 Notice and Non-Compliance Letter remains ongoing, and no assurances can be given regarding further action by the FDA as a result of the observations, including but not limited to action pursuant to the Consent Decree, or that corrective actions proposed by CareFusion 303, Inc. will be adequate to address these observations. Additionally, we cannot currently predict the amount of additional monetary investment that will be incurred to resolve this matter or the matter&#8217;s ultimate impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consent Decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing infusion pumps, recall products and take other actions. We may be required to pay damages of $15,000 per day per violation if we fail to comply with any provision of the Consent Decree, up to $15 million per year. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be obligated to pay more costs in the future because, among other things, the FDA may determine that we are not fully compliant with the Consent Decree and Non-Compliance Letter and therefore impose penalties under the Consent Decree, and/or we may also be subject to future proceedings and litigation relating to the matters addressed in the Consent Decree, including, but not limited to, additional fines, penalties, other monetary remedies, and expansion of the terms of the Consent Decree.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are undertaking certain remediation of our BD Alaris&#8482; System, and are currently shipping the product in the United States only in cases of medical necessity and to remediate recalled software versions.  As previously disclosed, we submitted our 510(k) premarket notification to the FDA for the BD Alaris&#8482; System in April 2021. The 510(k) submission is intended to bring the regulatory clearance for the BD Alaris&#8482; System up-to-date, address open recall issues, and provide other updates and features, including a new version of BD Alaris&#8482; System software that will provide clinical, operational and cybersecurity updates. We will not be able to fully resume commercial operations for the BD Alaris&#8482; System in the United States until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of risks relating to the regulations to which we are subject, see Part I, Item 1A, of our 2022 Annual Report.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes forward-looking statements within the meaning of the federal securities laws.  BD and its representatives may also, from time to time, make certain forward-looking statements in publicly released materials, both written and oral, including statements contained in filings with the SEC, press releases, and our reports to shareholders. Forward-looking statements may be identified by the use of words such as &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;estimate&#8221; and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements that address our future operating performance or events or developments that we expect or anticipate will occur in the future are forward-looking statements.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are, and will be, based on management&#8217;s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates.  Investors should realize that if underlying assumptions prove inaccurate, or risks or uncertainties materialize, actual results could vary materially from our expectations and projections.  Investors are therefore cautioned not to place undue reliance on any forward-looking statements.  Furthermore, we undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events and developments or otherwise, except as required by applicable law or regulations.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements.  The Russia and Ukraine conflict and the international response thereto may also heighten the impact of certain of these factors described below and the Risk Factors in our 2022 Annual Report.  For further discussion of certain of these factors, see Item&#160;1A. Risk Factors in our 2022 Annual Report.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of inflation and disruptions in our global supply chain on BD and our suppliers (particularly sole-source suppliers and providers of sterilization services), including fluctuations in the cost and availability of oil-based resins and other raw materials, as well as certain components, used in the production or sterilization of our products, transportation constraints and delays, product shortages, energy shortages or increased energy costs, labor shortages in the United States and elsewhere, and increased operating and labor costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any impact the COVID-19 pandemic, including resurgences in COVID-19 infections or new strains of the virus or additional or extended lockdowns or other restrictions imposed by government entities, may have on our business, the global economy and the global healthcare system. This may include decreases in the demand for our products, disruptions to our operations or the operations of our suppliers and customers (including employee absenteeism) or disruptions to our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Factors such as the rate of vaccination, the effectiveness of vaccines against different strains, the rate of infections, and competitive factors that could impact the demand and pricing for our COVID-19 diagnostics testing.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to recruit and retain key employees and the impact of labor shortages or increased employee turnover rates within our employee base, which could increase our operating costs and negatively affect our ability to efficiently operate our business.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General global, regional or national economic downturns and macroeconomic trends, including heightened inflation, capital market volatility, interest rate and currency rate fluctuations, and economic slowdown or recession, that may result in unfavorable conditions that could negatively affect demand for our products and services, impact the prices we can charge for our products and services, or impair our ability to produce our products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way healthcare services are delivered, including transition of more care from acute to non-acute settings and increased focus on chronic disease management, which may affect the demand for our products and services. Additionally, budget constraints and staffing shortages, particularly shortages of nursing staff, may affect the prioritization of healthcare services, which could also impact the demand for certain of our products and services.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive factors that could adversely affect our operations, including new product introductions and technologies (for example, new forms of drug delivery) by our current or future competitors, consolidation or strategic alliances among healthcare companies, distributors and/or payers of healthcare to improve their competitive position or develop new models for the delivery of healthcare, increased pricing pressure due to the impact of low-cost manufacturers, patents attained by competitors (particularly as patents on our products expire), new entrants into our markets and changes in the practice of medicine.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks relating to our overall level of indebtedness, including our ability to service our debt and refinance our indebtedness, which is dependent upon the capital markets and the overall macroeconomic environment and our financial condition at such time.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The adverse financial impact resulting from unfavorable changes in foreign currency exchange rates.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as our earnings forecasts are based on projected sales volumes and pricing of many product types, some of which are more profitable than others.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in reimbursement practices of governments or third-party payers, or adverse decisions relating to our products by such payers, which could reduce demand for our products or the price we can charge for such products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost-containment efforts in the U.S. or in other countries in which we do business, such as alternative payment reform and increased use of competitive bidding and tenders, including, without limitation, any expansion of the volume-based procurement process in China or implementation of similar cost-containment efforts.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the domestic and foreign healthcare industry or in medical practices that result in a reduction in procedures using our products or increased pricing pressures, including cost-reduction measures instituted by and the continued consolidation among healthcare providers.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing customer preferences and requirements, such as increased demand for products with lower environmental footprints, and for companies to produce and demonstrate progress against greenhouse gas reduction plans and targets.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. federal or foreign laws and policies that could affect fiscal and tax policies, taxation (including tax reforms that could adversely impact multinational corporations), and international trade, including import and export regulation and international trade agreements. In particular, tariffs or other trade barriers imposed by the U.S. or other countries could adversely impact our supply chain costs or otherwise adversely impact our results of operations.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risks associated with the spin-off of our former Diabetes Care business, including factors that could adversely affect our ability to realize the expected benefits of the spin-off, or the qualification of the spin-off as a tax-free transaction for U.S. federal income tax purposes.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information systems or our products, which could impair our ability to conduct business, result in the loss of BD trade secrets or otherwise compromise sensitive information of BD or its customers, suppliers and other business partners, or of patients, including sensitive personal data, or result in product efficacy or safety concerns for certain of our products, and result in actions by regulatory bodies or civil litigation.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory approvals and registrations in the United States and abroad, obtain intellectual property protection for our products, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of infringement claims by competitors with respect to patents or other intellectual property rights, all of which could preclude or delay commercialization of a product. Delays in obtaining necessary approvals or clearances from the FDA or other regulatory agencies or changes in the regulatory process may also delay product launches and increase development costs.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of business combinations or divestitures, including any volatility in earnings relating to acquisition-related costs, and our ability to successfully integrate any business we may acquire.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to penetrate or expand our operations in emerging markets, which depends on local economic and political conditions, and how well we are able to make necessary infrastructure enhancements to production facilities and distribution networks.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conditions in international markets, including social and political conditions, civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures, difficulties in protecting and enforcing our intellectual property rights and governmental expropriation of assets. Our international operations also increase our compliance risks, including risks under the Foreign Corrupt Practices Act and other anti-corruption laws, as well as regulatory and privacy laws.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deficit reduction efforts or other actions that reduce the availability of government funding for healthcare and research, which could weaken demand for our products and result in additional pricing pressures, as well as create potential collection risks associated with such sales.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in university or U.S. and international governmental funding and policies for life sciences research.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Fluctuations in the demand for products we sell to pharmaceutical companies that are used to manufacture, or are sold with, the products of such companies, as a result of funding constraints, consolidation or otherwise.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effects of regulatory or other events that adversely impact our supply chain, including our ability to manufacture (including sterilize) our products (particularly where production of a product line or sterilization operations are concentrated in one or more plants), source materials or components or services from suppliers (including sole-source suppliers) that are needed for such manufacturing (including sterilization), or provide products to our customers, including events that impact key distributors. </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Natural disasters, including the impacts of climate change, hurricanes, tornadoes, windstorms, fires, earthquakes and floods and other extreme weather events, global health pandemics, war, terrorism, labor disruptions and international conflicts that could cause significant economic disruption and political and social instability, resulting in decreased </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand for our products, adversely affect our manufacturing and distribution capabilities or cause interruptions in our supply chain.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pending and potential future litigation or other proceedings asserting, and/or investigations concerning and/or subpoenas and requests seeking information with respect to, alleged violations of law (including in connection with federal and/or state healthcare programs (such as Medicare or Medicaid) and/or sales and marketing practices (such as investigative subpoenas and the civil investigative demands received by BD)), potential anti-corruption and related internal control violations under the Foreign Corrupt Practices Act, antitrust claims, securities law claims, product liability (which may involve lawsuits seeking class action status or seeking to establish multi-district litigation proceedings, including pending claims relating to our hernia repair implant products, surgical continence products for women and vena cava filter products), claims with respect to environmental matters, data privacy breaches and patent infringement, and the availability or collectability of insurance relating to any such claims.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New or changing laws and regulations affecting our domestic and foreign operations, or changes in enforcement practices, including, without limitation, laws relating to sales practices, environmental protection, price controls, privacy, cybersecurity, and licensing and regulatory requirements for new products and products in the post-marketing phase. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials that may require us to re-register products already on the market or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product efficacy or safety concerns regarding our products resulting in product holds or recalls, regulatory action on the part of the FDA or foreign counterparts (including restrictions on future product clearances and civil penalties), declining sales and product liability claims, and damage to our reputation. As a result of the CareFusion acquisition, our U.S. infusion pump business is operating under a Consent Decree with the FDA. The Consent Decree authorizes the FDA, in the event of any violations in the future, to order our U.S. infusion pump business to cease manufacturing and distributing products, recall products or take other actions, and order the payment of significant monetary damages if the business subject to the decree fails to comply with any provision of the Consent Decree. We are undertaking certain remediation of our BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, and are currently shipping the product in the U.S., only in cases of medical necessity and to remediate recalled software versions. We will not be able to fully resume commercial operations for the BD Alaris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System in the U.S. until BD&#8217;s 510(k) submission relating to the product has been cleared by the FDA. No assurances can be given as to when or if clearance will be obtained from the FDA.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of adverse media exposure or other publicity regarding BD&#8217;s business or operations, including the effect on BD&#8217;s reputation or demand for its products.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of market fluctuations on the value of assets in BD&#8217;s pension plans and on actuarial interest rate and asset return assumptions, which could require BD to make additional contributions to the plans or increase our pension plan expense.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs, if any, that we may undertake.</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issuance of new or revised accounting standards by the FASB or the SEC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in information reported since the end of the fiscal year ended September&#160;30, 2022.</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controls and Procedures</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was carried out by BD&#8217;s management, with the participation of BD&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD&#8217;s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of December&#160;31, 2022.  Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these entities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the fiscal quarter ended December&#160;31, 2022 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, BD&#8217;s internal control over financial reporting.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_85"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved, both as a plaintiff and a defendant, in various legal proceedings, including product liability and environmental matters as set forth in our 2022 Annual Report, and in Note 5 of the Notes to Condensed Consolidated Financial Statements in this report, which is incorporated herein by reference.  </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item&#160;1A, of our 2022 Annual Report.</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth certain information regarding our purchases of common stock of BD during the quarter ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issuer Purchases of Equity Securities</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the three months ended December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average&#160;Price<br/>Paid per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>as Part of<br/>Publicly<br/>Announced&#160;Plans<br/>or Programs </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Maximum&#160;Number<br/>of&#160;Shares&#160;that&#160;May<br/>Yet Be Purchased<br/>Under&#160;the&#160;Plans&#160;or<br/>Programs (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1 &#8211; 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1 &#8211; 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.54&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,799,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 2,523 shares purchased during the quarter in open market transactions by the trust relating to BD&#8217;s Deferred Compensation and Retirement Benefit Restoration Plan and 1996 Directors&#8217; Deferral Plan.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents shares available under a repurchase program authorized by the Board of Directors on November 3, 2021 for 10 million shares, for which there is no expiration date.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_97"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_100"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Information</span></div><div style="margin-top:6pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i38cf244bc5b742d8ae124c6f37f53505_103"></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:6.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.741%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex2212312022.htm">22</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Subsidiary Issuer of Guaranteed Securities.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3112312022.htm">31</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rule 13a - 14(a).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3212312022.htm">32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63 of Title 18 of the U.S. Code.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from this report, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i38cf244bc5b742d8ae124c6f37f53505_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Becton,&#160;Dickinson&#160;and&#160;Company</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February&#160;2, 2023 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. DelOrefice</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas J. Spoerel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><noscript><img src="https://www.sec.gov/akam/13/pixel_32cda1fc?a=dD1mNWU0ODJjODJkNzUzYmRkNjFjMzJiOTg2YzQ1MjNjYzI0ZDZjYmEyJmpzPW9mZg==" style="visibility: hidden; position: absolute; left: -999px; top: -999px;" /></noscript></body></html>
